informatiestandaarden - Gebruikersbijdragen [nl]

mp:V2.0.0 testgegevens medicatiegegevens raadplegen WDS

2022-11-17T11:56:57Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens raadplegend systeem (WDS)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''R'''aadplegend systeem (MP-MGR) '''wisselenddoseerschema'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Stuur voor de genoemde patiënt het 'Medicatiegegevens raadplegen' bericht.
# De simulator verstuurt een 'Medicatiegegevens beschikbaarstellen' bericht met inhoudelijke gegevens.
# Verwerk dit bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier ontvangt als medicatiegegevens raadplegend systeem. Dit zijn de gegevens voor wisselenddoseerschema.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

== Scenarioset 0: filterqueries ==
Wordt nog uitgewerkt.

== Scenarioset 11: wisselenddoseerschema - diversen ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|overview-MGR-11}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|patient-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-3}}
<br>

== Scenarioset 13: relatie contact en episode ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|overview-MGR-13}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|patient-mg-mp-mg-tst-WDS-Scenarioset13-v20-13-3 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset13-v20-13-3}}

<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens wisselend doseerschema addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens beschikbaarstellen WDS

2022-11-17T11:55:38Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens beschikbaarstellend systeem (WDS)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''B'''eschikbaarstellend systeem (MP-MGB) '''wisselenddoseerschema'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Voer de gegevens van alle te testen wisselenddoseerschemas in voor de persoon genoemd in Persoonsgegevens.
# De simulator verstuurt een 'Medicatiegegevens raadplegen' bericht.
# Ontvang het 'Medicatiegegevens raadplegen' bericht en beantwoord deze met een 'Medicatiegegevens beschikbaarstellen' bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier beschikbaar moet stellen als medicatiegegevens beschikbaarstellend systeem. Dit zijn de gegevens voor wisselenddoseerschema.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

=== Beschikbaarstellend systeem===
Het beschikbaarstellend systeem voert de gegevens uit de paragrafen "Inhoudelijke gegevens" in het XIS in. Voor een beschikbaarstellend systeem geldt dat sommige gegevens door dit systeem bepaald mogen of moeten worden:

* Zorgverlener, zorgaanbieder (denk aan verstrekker, voorschrijver). Dit mag een eigen (test)zorgverlener en organisatie zijn.
* Identificatie van medicatiebouwstenen (wisselenddoseerschema). LET OP: verwacht wordt dat hier 'eigen' identificaties aan worden toegekend in een eigen identificatiesysteem (eigen OID). De onderlinge referenties moeten natuurlijk wel kloppen (dus een wisselenddoseerschema hoort bij dezelfde medicamenteuze behandeling als de medicatieafspraak vanuit de voorschrijver).

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

== Scenarioset 0: filterqueries ==
Wordt nog uitgewerkt.

== Scenarioset 11: wisselenddoseerschema - diversen ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|overview-MGR-11}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|patient-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-3}}
<br>

== Scenarioset 13: relatie contact en episode ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|overview-MGR-13}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|patient-mg-mp-mg-tst-WDS-Scenarioset13-v20-13-3 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|mbhs-mg-mp-mg-tst-WDS-Scenarioset13-v20-13-3}}

<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_WDS_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens wisselend doseerschema addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens WDS addendum

2022-11-17T11:54:30Z

Tim Schuller:

__NUMBEREDHEADINGS__
{{DISPLAYTITLE:Beschikbaarstellen en sturen MP9 2.0 - WDS: addendum inhoudelijke gegevens kwalificatie}}

=Addenda voor inhoudelijke gegevens=
== Overzicht van scenario's voor sturend/beschikbaarstellend systeem ==

=== Scenarioset 11===
<section begin=overview-MGB-11 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| WDS id
|-style="vertical-align:top;|style="background-color: white;"
|11.1|| || Opstartschema door voorschrijver|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_WDS_opstartschema
|-style="vertical-align:top;|style="background-color: white;"
|11.2|| || Schema door trombosedienst|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_WDS_trombosedienst
|-style="vertical-align:top;|style="background-color: white;"
|11.3|| || Wijziging door trombosedienst|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_WDS_technischestop<br/>MBH_200_wdsmtd1_WDS_verhoging
|}
<section end=overview-MGB-11 />
=== Scenarioset 13===
<section begin=overview-MGB-13 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| WDS id
|-style="vertical-align:top;|style="background-color: white;"
|13.3|| || Contact Episode|| MBH_200_contactepisode|| MBH_200_contactepisode_WDS_opstartschema
|}
<section end=overview-MGB-13 />
== Overzicht van scenario's voor ontvangend/raadplegend systeem ==

=== Scenarioset 11===
<section begin=overview-MGR-11 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| WDS id
|-style="vertical-align:top;|style="background-color: white;"
|11.1|| Opstartschema door voorschrijver|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_WDS_opstartschema
|-style="vertical-align:top;|style="background-color: white;"
|11.2|| Schema door trombosedienst|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_WDS_trombosedienst
|-style="vertical-align:top;|style="background-color: white;"
|11.3|| Wijziging door trombosedienst|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_WDS_technischestop<br/>MBH_200_wdsmtd1_WDS_verhoging
|}
<section end=overview-MGR-11 />
=== Scenarioset 13===
<section begin=overview-MGR-13 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| WDS id
|-style="vertical-align:top;|style="background-color: white;"
|13.3|| Contact Episode|| MBH_200_contactepisode|| MBH_200_contactepisode_WDS_opstartschema
|}
<section end=overview-MGR-13 />
== TEST Medicatiegegevens WDS Scenarioset 11==
<section begin=mg-mp-mg-tst-WDS-Scenarioset11-v20-11-1 /><section begin=patient-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Roelofs
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900973 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-1 /><section begin=mbhs-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-1 />
==== Scenario 11.1 - MBH_200_wdsmtd1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Wisselend doseerschema MBH_200_wdsmtd1_WDS_opstartschema
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Wisselend doseerschema datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 15 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 15 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 15 dagen, eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks, dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 1
|style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-1 /><section end=mg-mp-mg-tst-WDS-Scenarioset11-v20-11-1 />
== TEST Medicatiegegevens WDS Scenarioset 11==
<section begin=mg-mp-mg-tst-WDS-Scenarioset11-v20-11-2 /><section begin=patient-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Roelofs
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900973 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-2 /><section begin=mbhs-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-2 />
==== Scenario 11.2 - MBH_200_wdsmtd1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Wisselend doseerschema MBH_200_wdsmtd1_WDS_trombosedienst
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Wisselend doseerschema datum tijd
|style="background-color: white;"|T - 15 dagen om 14:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T - 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T - 5 dagen, cyclus van 5 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 1
|style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 3
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Herhaalperiode cyclisch schema
|style="background-color: white;"|5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie wisselend doseerschema
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Tanja_de_Bakker" title="Intern ID = Tanja_de_Bakker">Zorgverlener Tanja_de_Bakker</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Tanja de Bakker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Trombosedienst_Ons_Dorp|Zorgaanbieder: Trombosedienst_Ons_Dorp]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Trombosedienst_Ons_Dorp" title="Intern ID = Trombosedienst_Ons_Dorp">Zorgaanbieder Trombosedienst_Ons_Dorp</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|11112222 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Trombosedienst Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Afdeling specialisme
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|: Kerkstraat 28 d 1332GH Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-2 /><section end=mg-mp-mg-tst-WDS-Scenarioset11-v20-11-2 />
== TEST Medicatiegegevens WDS Scenarioset 11==
<section begin=mg-mp-mg-tst-WDS-Scenarioset11-v20-11-3 /><section begin=patient-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Roelofs
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900973 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-3 /><section begin=mbhs-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-3 />
==== Scenario 11.3 - MBH_200_wdsmtd1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Wisselend doseerschema MBH_200_wdsmtd1_WDS_technischestop
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_WDS_technischestop (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Wisselend doseerschema datum tijd
|style="background-color: white;"|T - 7 dagen om 10:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T - 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Wisselend doseerschema stop type
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden wijzigen of staken
|style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 14 dagen, tot en met T - 7 dagen, cyclus van 5 dagen: steeds eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds, dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds, Oraal, definitief gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 1
|style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag 2 stuks 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 2 stuks 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 3
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 0 stuks 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Herhaalperiode cyclisch schema
|style="background-color: white;"|5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toelichting
|style="background-color: white;"|Dosering aangepast i.v.m. te lage INR waarde.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie wisselend doseerschema
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Wisselend doseerschema MBH_200_wdsmtd1_WDS_verhoging
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_WDS_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Wisselend doseerschema datum tijd
|style="background-color: white;"|T - 7 dagen om 10:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 6 dagen, tot en met T + 6 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 6 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 6 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Tanja_de_Bakker|Zorgverlener: Tanja_de_Bakker]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 6 dagen, tot en met T + 6 dagen, cyclus van 5 dagen: steeds eerst gedurende 3 dagen 1 maal per dag om 19:00 2 stuks, dan gedurende 2 dagen 1 maal per dag om 19:00 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 1
|style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag om 19:00 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag om 19:00 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Herhaalperiode cyclisch schema
|style="background-color: white;"|5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie wisselend doseerschema
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_WDS_trombosedienst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Tanja_de_Bakker" title="Intern ID = Tanja_de_Bakker">Zorgverlener Tanja_de_Bakker</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Tanja de Bakker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Trombosedienst_Ons_Dorp|Zorgaanbieder: Trombosedienst_Ons_Dorp]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Trombosedienst_Ons_Dorp" title="Intern ID = Trombosedienst_Ons_Dorp">Zorgaanbieder Trombosedienst_Ons_Dorp</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|11112222 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Trombosedienst Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Afdeling specialisme
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|: Kerkstraat 28 d 1332GH Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-WDS-Scenarioset11-v20-11-3 /><section end=mg-mp-mg-tst-WDS-Scenarioset11-v20-11-3 />
== TEST Medicatiegegevens WDS Scenarioset 13==
<section begin=mg-mp-mg-tst-WDS-Scenarioset13-v20-13-3 /><section begin=patient-mg-mp-mg-tst-WDS-Scenarioset13-v20-13-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Smitsz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901072 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|19 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-WDS-Scenarioset13-v20-13-3 /><section begin=mbhs-mg-mp-mg-tst-WDS-Scenarioset13-v20-13-3 />
==== Scenario 13.3 - MBH_200_contactepisode====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Wisselend doseerschema MBH_200_contactepisode_WDS_opstartschema
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_contactepisode_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Wisselend doseerschema datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 15 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 15 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 15 dagen, eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks, dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 1
|style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag om 20:00 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 3 dagen 1 maal per dag om 20:00 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie contact
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatienummer
|style="background-color: white;"|MBH_200_contactepisode_CONTACT1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie zorgepisode
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatienummer
|style="background-color: white;"|MBH_200_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-WDS-Scenarioset13-v20-13-3 /><section end=mg-mp-mg-tst-WDS-Scenarioset13-v20-13-3 />

[[Categorie:Kwalificatie]]

mp:V2.0.0 testgegevens medicatiegegevens raadplegen MTD

2022-11-17T11:53:30Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens raadplegend systeem (MTD)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''R'''aadplegend systeem (MP-MGR) '''medicatietoediening'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Stuur voor de genoemde patiënt het 'Medicatiegegevens raadplegen' bericht.
# De simulator verstuurt een 'Medicatiegegevens beschikbaarstellen' bericht met inhoudelijke gegevens.
# Verwerk dit bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier ontvangt als medicatiegegevens raadplegend systeem. Dit zijn de gegevens voor medicatietoediening.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

== Scenarioset 0: filterqueries ==
Wordt nog uitgewerkt.

== Scenarioset 11: toedieningen - diverse inhoud ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|overview-MGR-11}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|patient-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-3}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-4}}
<br>

== Scenarioset 13: relatie contact en episode ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|overview-MGR-13}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|patient-mg-mp-mg-tst-MTD-Scenarioset13-v20-13-4 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|mbhs-mg-mp-mg-tst-MTD-Scenarioset13-v20-13-4}}
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens medicatietoediening addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens beschikbaarstellen MTD

2022-11-17T11:52:43Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens beschikbaarstellend systeem (MTD)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''B'''eschikbaarstellend systeem (MP-MGB) '''medicatietoediening'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Voer de gegevens van alle te testen medicatietoedieningen in voor de persoon genoemd in Persoonsgegevens.
# De simulator verstuurt een 'Medicatiegegevens raadplegen' bericht.
# Ontvang het 'Medicatiegegevens raadplegen' bericht en beantwoord deze met een 'Medicatiegegevens beschikbaarstellen' bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier beschikbaar moet stellen als medicatiegegevens beschikbaarstellend systeem. Dit zijn de gegevens voor medicatietoediening.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

=== Beschikbaarstellend systeem===
Het beschikbaarstellend systeem voert de gegevens uit de paragrafen "Inhoudelijke gegevens" in het XIS in. Voor een beschikbaarstellend systeem geldt dat sommige gegevens door dit systeem bepaald mogen of moeten worden:

* Zorgverlener, zorgaanbieder (denk aan verstrekker, voorschrijver). Dit mag een eigen (test)zorgverlener en organisatie zijn.
* Identificatie van medicamenteuze behandeling, medicatiebouwstenen (medicatietoediening). LET OP: verwacht wordt dat hier 'eigen' identificaties aan worden toegekend in een eigen identificatiesysteem (eigen OID). De onderlinge referenties moeten natuurlijk wel kloppen (dus een medicatietoediening hoort bij dezelfde medicamenteuze behandeling als de toedieningsafspraak vanuit de verstrekker). De identificatie van medicamenteuze behandeling mag niet door het beschikbaarstellend systeem bepaald worden indien het aanpassingen (of aanvullende bouwstenen) betreft op andermans medicamenteuze behandeling.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

== Scenarioset 0: filterqueries ==
Wordt nog uitgewerkt.

== Scenarioset 11: toedieningen - diverse inhoud ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|overview-MGR-11}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|patient-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-3}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-4}}
<br>

== Scenarioset 13: relatie contact en episode ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|overview-MGR-13}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|patient-mg-mp-mg-tst-MTD-Scenarioset13-v20-13-4 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|mbhs-mg-mp-mg-tst-MTD-Scenarioset13-v20-13-4}}
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-06-14
|style="background-color: white;"| Geannuleerd indicator niet van toepassing [https://bits.nictiz.nl/browse/MP-643 BITS MP-643]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-09-02
|style="background-color: white;"| Dubbele relatie gecorrigeerd naar één [https://bits.nictiz.nl/browse/MP-623 BITS MP-623]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_MTD_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens medicatietoediening addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens MTD addendum

2022-11-17T11:51:58Z

Tim Schuller:

__NUMBEREDHEADINGS__
{{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens 9 2.0 - MTD: addendum inhoudelijke gegevens kwalificatie}}

=Addenda voor inhoudelijke gegevens=
== Overzicht van scenario's voor sturend/beschikbaarstellend systeem ==

=== Scenarioset 11===
<section begin=overview-MGB-11 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id
|-style="vertical-align:top;|style="background-color: white;"
|11.1|| || Toediening auteur is mantelzorger|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_MTD1
|-style="vertical-align:top;|style="background-color: white;"
|11.2|| || Afwijkende toediening|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_MTD2
|-style="vertical-align:top;|style="background-color: white;"
|11.3|| || Toediening auteur is patient|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_MTD3
|-style="vertical-align:top;|style="background-color: white;"
|11.4|| || Niet toegediend|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_MTD4
|}
<section end=overview-MGB-11 />
=== Scenarioset 13===
<section begin=overview-MGB-13 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MTD id
|-style="vertical-align:top;|style="background-color: white;"
|13.4|| || Contact Episode|| MBH_200_contactepisode|| MBH_200_contactepisode_MTD1
|}
<section end=overview-MGB-13 />
== Overzicht van scenario's voor ontvangend/raadplegend systeem ==

=== Scenarioset 11===
<section begin=overview-MGR-11 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MTD id
|-style="vertical-align:top;|style="background-color: white;"
|11.1|| Toediening auteur is mantelzorger|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_MTD1
|-style="vertical-align:top;|style="background-color: white;"
|11.2|| Afwijkende toediening|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_MTD2
|-style="vertical-align:top;|style="background-color: white;"
|11.3|| Toediening auteur is patient|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_MTD3
|-style="vertical-align:top;|style="background-color: white;"
|11.4|| Niet toegediend|| MBH_200_wdsmtd1|| MBH_200_wdsmtd1_MTD4
|}
<section end=overview-MGR-11 />
=== Scenarioset 13===
<section begin=overview-MGR-13 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MTD id
|-style="vertical-align:top;|style="background-color: white;"
|13.4|| Contact Episode|| MBH_200_contactepisode|| MBH_200_contactepisode_MTD1
|}
<section end=overview-MGR-13 />
== TEST Medicatiegegevens MTD Scenarioset 11==
<section begin=mg-mp-mg-tst-MTD-Scenarioset11-v20-11-1 /><section begin=patient-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Roelofs
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900973 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-1 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-1 />
==== Scenario 11.1 - MBH_200_wdsmtd1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_200_wdsmtd1_MTD1
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedienings datum tijd
|style="background-color: white;"|T - 20 dagen om 20:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afgesproken datum tijd
|style="background-color: white;"|T - 20 dagen om 20:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Toegediende hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aantal
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Afgesproken hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aantal
|style="background-color: white;"|2
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsweg
|style="background-color: white;"|ORAAL (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Toediener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Mantelzorger
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Contactpersoon
|style="background-color: white;"|Zie [[#Toos_de_Bakker|Contactpersoon: Toos_de_Bakker]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Relatie wisselend doseerschema
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Toos_de_Bakker" title="Intern ID = Toos_de_Bakker">Contactpersoon Toos_de_Bakker</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Naamgegevens
|style="background-color: white;"|Toos de Bakker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Rol
|style="background-color: white;"|Mantelzorger (code = '100001' in codeSystem '2.16.840.1.113883.2.4.3.11.60.40.4.23.1')
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-1 /><section end=mg-mp-mg-tst-MTD-Scenarioset11-v20-11-1 />
== TEST Medicatiegegevens MTD Scenarioset 11==
<section begin=mg-mp-mg-tst-MTD-Scenarioset11-v20-11-2 /><section begin=patient-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Roelofs
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900973 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-2 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-2 />
==== Scenario 11.2 - MBH_200_wdsmtd1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_200_wdsmtd1_MTD2
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedienings datum tijd
|style="background-color: white;"|T - 19 dagen om 20:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Afgesproken datum tijd
|style="background-color: white;"|T - 19 dagen om 20:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toegediende hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aantal
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afgesproken hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aantal
|style="background-color: white;"|2
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toediener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Jantien_Toedien|Zorgverlener: Jantien_Toedien]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatie toediening reden van afwijken
|style="background-color: white;"|toediening van medicatie geweigerd (code = '406149000' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie wisselend doseerschema
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Jantien_Toedien" title="Intern ID = Jantien_Toedien">Zorgverlener Jantien_Toedien</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Jantien Toedien
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Thuiszorg_Om_en_Bij|Zorgaanbieder: Thuiszorg_Om_en_Bij]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Thuiszorg_Om_en_Bij" title="Intern ID = Thuiszorg_Om_en_Bij">Zorgaanbieder Thuiszorg_Om_en_Bij</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|11110000 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Thuiszorg Om en Bij
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|: Voorstraat 1 1223BA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie type
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '2.16.840.1.113883.2.4.15.1060')
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-2 /><section end=mg-mp-mg-tst-MTD-Scenarioset11-v20-11-2 />
== TEST Medicatiegegevens MTD Scenarioset 11==
<section begin=mg-mp-mg-tst-MTD-Scenarioset11-v20-11-3 /><section begin=patient-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Roelofs
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900973 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-3 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-3 />
==== Scenario 11.3 - MBH_200_wdsmtd1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_200_wdsmtd1_MTD3
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_MTD3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedienings datum tijd
|style="background-color: white;"|T - 17 dagen om 20:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Afgesproken datum tijd
|style="background-color: white;"|T - 17 dagen om 20:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toegediende hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aantal
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afgesproken hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aantal
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toediener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Jantien_Toedien|Zorgverlener: Jantien_Toedien]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatie toediening reden van afwijken
|style="background-color: white;"|niet in staat om medicatie te gebruiken (code = '408366001' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toelichting
|style="background-color: white;"|Geprobeerd, maar niet gelukt met de tablet
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie wisselend doseerschema
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Jantien_Toedien" title="Intern ID = Jantien_Toedien">Zorgverlener Jantien_Toedien</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Jantien Toedien
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Thuiszorg_Om_en_Bij|Zorgaanbieder: Thuiszorg_Om_en_Bij]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Thuiszorg_Om_en_Bij" title="Intern ID = Thuiszorg_Om_en_Bij">Zorgaanbieder Thuiszorg_Om_en_Bij</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|11110000 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Thuiszorg Om en Bij
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|: Voorstraat 1 1223BA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie type
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '2.16.840.1.113883.2.4.15.1060')
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-3 /><section end=mg-mp-mg-tst-MTD-Scenarioset11-v20-11-3 />
== TEST Medicatiegegevens MTD Scenarioset 11==
<section begin=mg-mp-mg-tst-MTD-Scenarioset11-v20-11-4 /><section begin=patient-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Roelofs
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900973 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|10 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-4 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-4 />
==== Scenario 11.4 - MBH_200_wdsmtd1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_200_wdsmtd1_MTD4
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_MTD4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedienings datum tijd
|style="background-color: white;"|T - 16 dagen om 20:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Afgesproken datum tijd
|style="background-color: white;"|T - 16 dagen om 20:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toegediende hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aantal
|style="background-color: white;"|0
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afgesproken hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aantal
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toediener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Marleen_van_der_Brand|Zorgverlener: Marleen_van_der_Brand]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatie toediening reden van afwijken
|style="background-color: white;"|zorgafnemer niet beschikbaar om medicatie in ontvangst te nemen (code = '153241000146104' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie wisselend doseerschema
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wdsmtd1_WDS_opstartschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wdsmtd1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Marleen_van_der_Brand" title="Intern ID = Marleen_van_der_Brand">Zorgverlener Marleen_van_der_Brand</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|111110000 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Marleen van der Brand
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Thuiszorg_Om_en_Bij|Zorgaanbieder: Thuiszorg_Om_en_Bij]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Thuiszorg_Om_en_Bij" title="Intern ID = Thuiszorg_Om_en_Bij">Zorgaanbieder Thuiszorg_Om_en_Bij</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|11110000 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Thuiszorg Om en Bij
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|: Voorstraat 1 1223BA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie type
|style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '2.16.840.1.113883.2.4.15.1060')
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset11-v20-11-4 /><section end=mg-mp-mg-tst-MTD-Scenarioset11-v20-11-4 />
== TEST Medicatiegegevens MTD Scenarioset 13==
<section begin=mg-mp-mg-tst-MTD-Scenarioset13-v20-13-4 /><section begin=patient-mg-mp-mg-tst-MTD-Scenarioset13-v20-13-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Smitsz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901072 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|19 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MTD-Scenarioset13-v20-13-4 /><section begin=mbhs-mg-mp-mg-tst-MTD-Scenarioset13-v20-13-4 />
==== Scenario 13.4 - MBH_200_contactepisode====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatietoediening MBH_200_contactepisode_MTD1
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_contactepisode_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedienings datum tijd
|style="background-color: white;"|T - 20 dagen om 20:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Afgesproken datum tijd
|style="background-color: white;"|T - 20 dagen om 20:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toegediende hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aantal
|style="background-color: white;"|2
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Afgesproken hoeveelheid
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aantal
|style="background-color: white;"|2
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Eenheid
|style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|ORAAL (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toediener
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie wisselend doseerschema
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA1_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie contact
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatienummer
|style="background-color: white;"|MBH_200_contactepisode_CONTACT2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie zorgepisode
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatienummer
|style="background-color: white;"|MBH_200_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MTD-Scenarioset13-v20-13-4 /><section end=mg-mp-mg-tst-MTD-Scenarioset13-v20-13-4 />

[[Categorie:Kwalificatie]]

mp:V2.0.0 testgegevens medicatiegegevens raadplegen MGB

2022-11-17T11:49:12Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens raadplegend systeem (MGB)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''R'''aadplegend systeem (MP-MGR) '''medicatiegebruik'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Stuur voor de genoemde patiënt het 'Medicatiegegevens raadplegen' bericht.
# De simulator verstuurt een 'Medicatiegegevens beschikbaarstellen' bericht met inhoudelijke gegevens.
# Verwerk dit bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier ontvangt als medicatiegegevens raadplegend systeem. Dit zijn de gegevens voor medicatiegebruik.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

== Scenarioset 0: filterqueries ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-0}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-1}}

<br>

== Scenarioset 1: medicatiegebruik basale inhoud - gebruiksperiode ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-1}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2a}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2b}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-3}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-4}}

<br>

== Scenarioset 2: medicatiegebruik basale inhoud - andere elementen ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-2}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-2 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-3}}
<br>
<br>
<br>
<br>

== Scenarioset 3 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 4 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 5: medicatiegebruik ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-5}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-3}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-4}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-5}}
<br>
<br>

== Scenarioset 6: medicatiegebruik met diverse doseerschema's ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-6}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-3}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-4}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-5}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-6}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7a}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7b}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-8}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-9}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-10}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-11}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-12}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-13}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-14}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-15}}

== Scenarioset 7: medicatiegebruik o.b.v. magistraal/eigen artikel ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-7}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-3}}

== Scenarioset 8 ==
Niet van toepassing.

== Scenarioset 9 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 10: geneesmiddel HPK en ZI-nr ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-10}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-2}}
<br>

== Scenarioset 13: relatie contact en episode ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-13}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset13-v20-13-5 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset13-v20-13-5}}
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens medicatiegebruik addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens beschikbaarstellen MGB

2022-11-17T11:48:34Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens beschikbaarstellend systeem (MGB)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''B'''eschikbaarstellend systeem (MP-MGB) '''medicatiegebruik'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Voer de gegevens van alle te testen medicatiegebruik in voor de persoon genoemd in Persoonsgegevens.
# De simulator verstuurt een 'Medicatiegegevens raadplegen' bericht.
# Ontvang het 'Medicatiegegevens raadplegen' bericht en beantwoord deze met een 'Medicatiegegevens beschikbaarstellen' bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier beschikbaar moet stellen als medicatiegegevens beschikbaarstellend systeem. Dit zijn de gegevens voor medicatiegebruik.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

=== Beschikbaarstellend systeem===
Het beschikbaarstellend systeem voert de gegevens uit de paragrafen "Inhoudelijke gegevens" in het XIS in. Voor een beschikbaarstellend systeem geldt dat sommige gegevens door dit systeem bepaald mogen of moeten worden:

* Zorgverlener, zorgaanbieder (denk aan verstrekker, voorschrijver). Dit mag een eigen (test)zorgverlener en organisatie zijn.
* Identificatie van medicamenteuze behandeling, medicatiebouwstenen (medicatiegebruik). LET OP: verwacht wordt dat hier 'eigen' identificaties aan worden toegekend in een eigen identificatiesysteem (eigen OID). De onderlinge referenties moeten natuurlijk wel kloppen (dus een toedieningsafspraak en een medicatieverstrekking blijven horen bij dezelfde medicamenteuze behandeling als de medicatieafspraak en verstrekkingsverzoek vanuit de voorschrijver). De identificatie van medicamenteuze behandeling mag niet door het beschikbaarstellend systeem bepaald worden indien het aanpassingen (of aanvullende bouwstenen) betreft op andermans medicamenteuze behandeling.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

== Scenarioset 0: filterqueries ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-0}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-1}}

<br>

== Scenarioset 1: medicatiegebruik basale inhoud - gebruiksperiode ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-1}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2a}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2b}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-3}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-4}}

<br>

== Scenarioset 2: medicatiegebruik basale inhoud - andere elementen ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-2}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-2 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-3}}
<br>
<br>
<br>
<br>

== Scenarioset 3 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 4 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 5: medicatiegebruik ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-5}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-3}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-4}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-5}}
<br>
<br>

== Scenarioset 6: medicatiegebruik met diverse doseerschema's ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-6}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-3}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-4}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-5}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-6}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7a}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7b}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-8}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-9}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-10}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-11}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-12}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-13}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-14}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-15}}

== Scenarioset 7: medicatiegebruik o.b.v. magistraal/eigen artikel ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-7}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-3}}

== Scenarioset 8 ==
Niet van toepassing.

== Scenarioset 9 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 10: geneesmiddel HPK en ZI-nr ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-10}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-2}}
<br>

== Scenarioset 13: relatie contact en episode ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|overview-MGR-13}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|patient-mg-mp-mg-tst-MGB-Scenarioset13-v20-13-5 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|mbhs-mg-mp-mg-tst-MGB-Scenarioset13-v20-13-5}}
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_MGB_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens medicatiegebruik addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens MGB addendum

2022-11-17T11:47:48Z

Tim Schuller:

__NUMBEREDHEADINGS__
{{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens 9 2.0 - MGB: addendum inhoudelijke gegevens kwalificatie}}

=Addenda voor inhoudelijke gegevens=
== Overzicht van scenario's voor sturend/beschikbaarstellend systeem ==

=== Scenarioset 0===
<section begin=overview-MGB-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| || Alle het medicatiegebruik van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 6x medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| || Specifieke medicatiegebruik met identificaties als filter (in kwalificatiesimulator het id van "MBH_200_QA1_MGB" invoeren)<br/>(Antwoord: bericht met 1 medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.3 optioneel|| || Medicatiegebruik met een filter op productcode (PRK 3956)<br/>(Antwoord: bericht met 1 medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| || Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21)<br/>(Antwoord: bericht met 4x medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| || Medicatiegebruik met een filter op gebruiksperiode – einddatum (alles voor T-22)<br/>(Antwoord: bericht met 3x medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.6|| || Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7)<br/>(Antwoord: bericht met 3x medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.7|| || Medicatiegebruik met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_200_QA1" invoeren)<br/>(Antwoord: bericht met 1 medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.8|| || Een antwoord zonder medicatiegebruik (filter op gebruiksperiode – einddatum (alles voor T-110))<br/>(Antwoord: bericht zonder medicatiegebruik)
|}
<section end=overview-MGB-0 />
=== Scenarioset 1===
<section begin=overview-MGB-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|1.1*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| Medicatiegebruik gebruiksperiode ingangsdatum en einddatum|| MBH_200_start_eind|| MBH_200_start_eind_MGB
|-style="vertical-align:top;|style="background-color: white;"
|1.2a*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Medicatiegebruik gebruiksperiode ingangsdatum en duur (weken)|| MBH_200_start_duur|| MBH_200_start_duur_MGB
|-style="vertical-align:top;|style="background-color: white;"
|1.2b*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Medicatiegebruik gebruiksperiode ingangsdatum en duur (dagen)|| MBH_200_start_duur2|| MBH_200_start_duur2_MGB
|-style="vertical-align:top;|style="background-color: white;"
|1.3|| || Medicatiegebruik gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_200_chronisch|| MBH_200_chronisch_MGB
|-style="vertical-align:top;|style="background-color: white;"
|1.4|| || Medicatiegebruik met eenheid 'dosis/stuks'|| MBH_200_dosis_stuks|| MBH_200_dosis_stuks_MGB
|}
<section end=overview-MGB-1 />
=== Scenarioset 2===
<section begin=overview-MGB-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_200_toelichting|| MBH_200_toelichting_MGB
|-style="vertical-align:top;|style="background-color: white;"
|2.3|| || Reden wijzigen of stoppen gebruik|| MBH_200_redenvanvoorschrijven|| MBH_200_redenvanvoorschrijven_MGB
|}
<section end=overview-MGB-2 />
=== Scenarioset 5===
<section begin=overview-MGB-5 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|5.1|| || Volgens afspraak|| MBH_200_volgens_afspraak|| MBH_200_volgens_afspraak_MGB
|-style="vertical-align:top;|style="background-color: white;"
|5.2|| || Afwijkend gebruik|| MBH_200_niet_volgens_afspraak|| MBH_200_niet_volgens_afspraak_MGB
|-style="vertical-align:top;|style="background-color: white;"
|5.3|| || Geen gebruik tegen afspraak in|| MBH_200_geen_gebruik_niet_volgens_afspraak|| MBH_200_geen_gebruik_niet_volgens_afspraak_MGB
|-style="vertical-align:top;|style="background-color: white;"
|5.4|| || Geen gebruik volgens afspraak|| MBH_200_geen_gebruik_volgens_afspraak|| MBH_200_geen_gebruik_volgens_afspraak_MGB
|-style="vertical-align:top;|style="background-color: white;"
|5.5|| || Zelfzorgmedicatie|| MBH_200_zelfzorgmedicatie|| MBH_200_zelfzorgmedicatie_MBG
|}
<section end=overview-MGB-5 />
=== Scenarioset 6===
<section begin=overview-MGB-6 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|6.1|| || Variabele frequentie|| MBH_200_variabelefrequentie|| MBH_200_variabelefrequentie_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.2|| || Interval|| MBH_200_interval|| MBH_200_interval_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.3|| || Variabele hoeveelheid (1)|| MBH_200_variabelehoeveelheid|| MBH_200_variabelehoeveelheid_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.4|| || Zonder keerdosis|| MBH_200_zonderkeerdosis|| MBH_200_zonderkeerdosis_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.5|| || Bijzondere keerdosis|| MBH_200_bijzonderekeerdosis|| MBH_200_bijzonderekeerdosis_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.6|| || Variabele hoeveelheid (2)|| MBH_200_variabelehoeveelheid2|| MBH_200_variabelehoeveelheid2_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.7a|| || Tijdstippen flexibel|| MBH_200_tijdstippen_flexibel|| MBH_200_tijdstippen_flexibel_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.7b|| || Tijdstippen niet flexibel|| MBH_200_tijdstippen_niet_flexibel|| MBH_200_tijdstippen_niet_flexibel_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.8|| || Weekdagen|| MBH_200_weekdagen|| MBH_200_weekdagen_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.9|| || Dagdeel|| MBH_200_dagdeel|| MBH_200_dagdeel_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.10|| || Cyclisch schema|| MBH_200_cyclischschema|| MBH_200_cyclischschema_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.11|| || Afbouw schema en doseerduur|| MBH_200_afbouwschema|| MBH_200_afbouwschema_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.12|| || Variabele hoeveelheid en maximum|| MBH_200_variabelehoeveelheidenmaximum|| MBH_200_variabelehoeveelheidenmaximum_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.13|| || toedieningssnelheid|| MBH_200_toedieningssnelheid|| MBH_200_toedieningssnelheid_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.14|| || Toedieningsduur|| MBH_200_toedieningsduur|| MBH_200_toedieningsduur_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.15|| || Zo nodig|| MBH_200_zonodig|| MBH_200_zonodig_MGB
|}
<section end=overview-MGB-6 />
=== Scenarioset 7===
<section begin=overview-MGB-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|7.1|| || Alle ingredienten|| MBH_200_magistraalalleingredienten|| MBH_200_magistraalalleingredienten_MGB
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| || Actieve ingredient|| MBH_200_magistraalactieveingredient|| MBH_200_magistraalactieveingredient_MGB
|-style="vertical-align:top;|style="background-color: white;"
|7.3|| || 90 miljoen nr|| MBH_200_magistraal90miljoennr|| MBH_200_magistraal90miljoennr_MGB
|}
<section end=overview-MGB-7 />
=== Scenarioset 10===
<section begin=overview-MGB-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| || HPK niveau|| MBH_200_HPKvoorschrijven|| MBH_200_HPKvoorschrijven_MGB
|-style="vertical-align:top;|style="background-color: white;"
|10.2|| || ZInr niveau|| MBH_200_ZINRvoorschrijven|| MBH_200_ZINRvoorschrijven_MGB
|}
<section end=overview-MGB-10 />
=== Scenarioset 13===
<section begin=overview-MGB-13 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|13.5|| || Contact Episode|| MBH_200_contactepisode|| MBH_200_contactepisode_MGB
|}
<section end=overview-MGB-13 />
== Overzicht van scenario's voor ontvangend/raadplegend systeem ==

=== Scenarioset 0===
<section begin=overview-MGR-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| Alle het medicatiegebruik van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 6x medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| Specifieke medicatiegebruik met identificaties als filter (in kwalificatiesimulator het id van "MBH_200_QA1_MGB" invoeren)<br/>(Antwoord: bericht met 1 medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.3|| Medicatiegebruik met een filter op productcode (PRK 3956)<br/>(Antwoord: bericht met 1 medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21)<br/>(Antwoord: bericht met 4x medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| Medicatiegebruik met een filter op gebruiksperiode – einddatum (alles voor T-22)<br/>(Antwoord: bericht met 3x medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.6|| Medicatiegebruik met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7)<br/>(Antwoord: bericht met 3x medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.7|| Medicatiegebruik met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_200_QA1" invoeren)<br/>(Antwoord: bericht met 1 medicatiegebruik)
|-style="vertical-align:top;|style="background-color: white;"
|0.8|| Een antwoord zonder medicatiegebruik (filter op gebruiksperiode – einddatum (alles voor T-110))<br/>(Antwoord: bericht zonder medicatiegebruik)
|}
<section end=overview-MGR-0 />
=== Scenarioset 1===
<section begin=overview-MGR-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|1.1|| Medicatiegebruik gebruiksperiode ingangsdatum en einddatum|| MBH_200_start_eind|| MBH_200_start_eind_MGB
|-style="vertical-align:top;|style="background-color: white;"
|1.2a|| Medicatiegebruik gebruiksperiode ingangsdatum en duur (weken)|| MBH_200_start_duur|| MBH_200_start_duur_MGB
|-style="vertical-align:top;|style="background-color: white;"
|1.2b|| Medicatiegebruik gebruiksperiode ingangsdatum en duur (dagen)|| MBH_200_start_duur2|| MBH_200_start_duur2_MGB
|-style="vertical-align:top;|style="background-color: white;"
|1.3|| Medicatiegebruik gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_200_chronisch|| MBH_200_chronisch_MGB
|-style="vertical-align:top;|style="background-color: white;"
|1.4|| Medicatiegebruik met eenheid 'dosis/stuks'|| MBH_200_dosis_stuks|| MBH_200_dosis_stuks_MGB
|}
<section end=overview-MGR-1 />
=== Scenarioset 2===
<section begin=overview-MGR-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Toelichting|| MBH_200_toelichting|| MBH_200_toelichting_MGB
|-style="vertical-align:top;|style="background-color: white;"
|2.3|| Reden wijzigen of stoppen gebruik|| MBH_200_redenvanvoorschrijven|| MBH_200_redenvanvoorschrijven_MGB
|}
<section end=overview-MGR-2 />
=== Scenarioset 5===
<section begin=overview-MGR-5 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|5.1|| Volgens afspraak|| MBH_200_volgens_afspraak|| MBH_200_volgens_afspraak_MGB
|-style="vertical-align:top;|style="background-color: white;"
|5.2|| Afwijkend gebruik|| MBH_200_niet_volgens_afspraak|| MBH_200_niet_volgens_afspraak_MGB
|-style="vertical-align:top;|style="background-color: white;"
|5.3|| Geen gebruik tegen afspraak in|| MBH_200_geen_gebruik_niet_volgens_afspraak|| MBH_200_geen_gebruik_niet_volgens_afspraak_MGB
|-style="vertical-align:top;|style="background-color: white;"
|5.4|| Geen gebruik volgens afspraak|| MBH_200_geen_gebruik_volgens_afspraak|| MBH_200_geen_gebruik_volgens_afspraak_MGB
|-style="vertical-align:top;|style="background-color: white;"
|5.5|| Zelfzorgmedicatie|| MBH_200_zelfzorgmedicatie|| MBH_200_zelfzorgmedicatie_MBG
|}
<section end=overview-MGR-5 />
=== Scenarioset 6===
<section begin=overview-MGR-6 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|6.1|| Variabele frequentie|| MBH_200_variabelefrequentie|| MBH_200_variabelefrequentie_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.2|| Interval|| MBH_200_interval|| MBH_200_interval_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.3|| Variabele hoeveelheid (1)|| MBH_200_variabelehoeveelheid|| MBH_200_variabelehoeveelheid_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.4|| Zonder keerdosis|| MBH_200_zonderkeerdosis|| MBH_200_zonderkeerdosis_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.5|| Bijzondere keerdosis|| MBH_200_bijzonderekeerdosis|| MBH_200_bijzonderekeerdosis_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.6|| Variabele hoeveelheid (2)|| MBH_200_variabelehoeveelheid2|| MBH_200_variabelehoeveelheid2_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.7a|| Tijdstippen flexibel|| MBH_200_tijdstippen_flexibel|| MBH_200_tijdstippen_flexibel_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.7b|| Tijdstippen niet flexibel|| MBH_200_tijdstippen_niet_flexibel|| MBH_200_tijdstippen_niet_flexibel_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.8|| Weekdagen|| MBH_200_weekdagen|| MBH_200_weekdagen_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.9|| Dagdeel|| MBH_200_dagdeel|| MBH_200_dagdeel_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.10|| Cyclisch schema|| MBH_200_cyclischschema|| MBH_200_cyclischschema_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.11|| Afbouw schema en doseerduur|| MBH_200_afbouwschema|| MBH_200_afbouwschema_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.12|| Variabele hoeveelheid en maximum|| MBH_200_variabelehoeveelheidenmaximum|| MBH_200_variabelehoeveelheidenmaximum_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.13|| toedieningssnelheid|| MBH_200_toedieningssnelheid|| MBH_200_toedieningssnelheid_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.14|| Toedieningsduur|| MBH_200_toedieningsduur|| MBH_200_toedieningsduur_MGB
|-style="vertical-align:top;|style="background-color: white;"
|6.15|| Zo nodig|| MBH_200_zonodig|| MBH_200_zonodig_MGB
|}
<section end=overview-MGR-6 />
=== Scenarioset 7===
<section begin=overview-MGR-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|7.1|| Alle ingredienten|| MBH_200_magistraalalleingredienten|| MBH_200_magistraalalleingredienten_MGB
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| Actieve ingredient|| MBH_200_magistraalactieveingredient|| MBH_200_magistraalactieveingredient_MGB
|-style="vertical-align:top;|style="background-color: white;"
|7.3|| 90 miljoen nr|| MBH_200_magistraal90miljoennr|| MBH_200_magistraal90miljoennr_MGB
|}
<section end=overview-MGR-7 />
=== Scenarioset 10===
<section begin=overview-MGR-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| HPK niveau|| MBH_200_HPKvoorschrijven|| MBH_200_HPKvoorschrijven_MGB
|-style="vertical-align:top;|style="background-color: white;"
|10.2|| ZInr niveau|| MBH_200_ZINRvoorschrijven|| MBH_200_ZINRvoorschrijven_MGB
|}
<section end=overview-MGR-10 />
=== Scenarioset 13===
<section begin=overview-MGR-13 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MGB id
|-style="vertical-align:top;|style="background-color: white;"
|13.5|| Contact Episode|| MBH_200_contactepisode|| MBH_200_contactepisode_MGB
|}
<section end=overview-MGR-13 />
== TEST Medicatiegegevens MGB Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-1 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-1 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-1 />
==== Scenario 0.1 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA1_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 1 dag om 10:04:23 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA2_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 68 dagen om 12:13:55 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 72 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 millimeter, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 10 millimeter
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA3_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 9 dagen om 07:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA4_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 2 dagen om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA5====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA5_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA5_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 43 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|4 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA6====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA6_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA6_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 2 dagen om 08:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-1 /><section end=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-1 />
== TEST Medicatiegegevens MGB Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-2 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-2 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-2 />
==== Scenario 0.2 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA1_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 1 dag om 10:04:23 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-2 /><section end=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-2 />
== TEST Medicatiegegevens MGB Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-3optioneel /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-3optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-3optioneel /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-3optioneel />
==== Scenario 0.3 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA4_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 2 dagen om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-3optioneel /><section end=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-3optioneel />
== TEST Medicatiegegevens MGB Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-4 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-4 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-4 />
==== Scenario 0.4 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA1_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 1 dag om 10:04:23 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA3_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 9 dagen om 07:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA4_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 2 dagen om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_200_QA6====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA6_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA6_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 2 dagen om 08:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-4 /><section end=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-4 />
== TEST Medicatiegegevens MGB Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-5 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-5 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-5 />
==== Scenario 0.5 - MBH_200_QA2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA2_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 68 dagen om 12:13:55 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 72 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 millimeter, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 10 millimeter
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.5 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA3_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 9 dagen om 07:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.5 - MBH_200_QA5====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA5_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA5_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 43 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|4 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-5 /><section end=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-5 />
== TEST Medicatiegegevens MGB Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-6 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-6 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-6 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-6 />
==== Scenario 0.6 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA1_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 1 dag om 10:04:23 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.6 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA3_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 9 dagen om 07:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.6 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA4_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 2 dagen om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-6 /><section end=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-6 />
== TEST Medicatiegegevens MGB Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-7 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-7 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-7 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-7 />
==== Scenario 0.7 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_QA1_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 1 dag om 10:04:23 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-7 /><section end=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-7 />
== TEST Medicatiegegevens MGB Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-8 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-8 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-8 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-8 /><section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset0-v20-0-8 /><section end=mg-mp-mg-tst-MGB-Scenarioset0-v20-0-8 />
== TEST Medicatiegegevens MGB Scenarioset 1==
<section begin=mg-mp-mg-tst-MGB-Scenarioset1-v20-1-1 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-1 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-1 />
==== Scenario 1.1 - MBH_200_start_eind====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_start_eind_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_start_eind_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 4 dagen om 10:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-1 /><section end=mg-mp-mg-tst-MGB-Scenarioset1-v20-1-1 />
== TEST Medicatiegegevens MGB Scenarioset 1==
<section begin=mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2a /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2a />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2a /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2a />
==== Scenario 1.2a - MBH_200_start_duur====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_start_duur_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_start_duur_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 1 dag om 12:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2a /><section end=mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2a />
== TEST Medicatiegegevens MGB Scenarioset 1==
<section begin=mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2b /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2b />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2b /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2b />
==== Scenario 1.2b - MBH_200_start_duur2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_start_duur2_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_start_duur2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 55 dagen om 15:21:33 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2b /><section end=mg-mp-mg-tst-MGB-Scenarioset1-v20-1-2b />
== TEST Medicatiegegevens MGB Scenarioset 1==
<section begin=mg-mp-mg-tst-MGB-Scenarioset1-v20-1-3 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-3 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-3 />
==== Scenario 1.3 - MBH_200_chronisch====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_chronisch_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_chronisch_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 20 dagen om 11:43:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-3 /><section end=mg-mp-mg-tst-MGB-Scenarioset1-v20-1-3 />
== TEST Medicatiegegevens MGB Scenarioset 1==
<section begin=mg-mp-mg-tst-MGB-Scenarioset1-v20-1-4 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-4 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-4 />
==== Scenario 1.4 - MBH_200_dosis_stuks====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_dosis_stuks_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_dosis_stuks_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 100 dagen om 07:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|2 maal per dag 1 dosis, inhalatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 dosis
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset1-v20-1-4 /><section end=mg-mp-mg-tst-MGB-Scenarioset1-v20-1-4 />
== TEST Medicatiegegevens MGB Scenarioset 2==
<section begin=mg-mp-mg-tst-MGB-Scenarioset2-v20-2-2 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-2 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-2 />
==== Scenario 2.2 - MBH_200_toelichting====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_toelichting_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_toelichting_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T om 10:14 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T - 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 7 dagen, tot en met T - 1 dag, 2 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toelichting
|style="background-color: white;"|In verband met bijwerking de afgelopen week minder vaak genomen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-2 /><section end=mg-mp-mg-tst-MGB-Scenarioset2-v20-2-2 />
== TEST Medicatiegegevens MGB Scenarioset 2==
<section begin=mg-mp-mg-tst-MGB-Scenarioset2-v20-2-3 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-3 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-3 />
==== Scenario 2.3 - MBH_200_redenvanvoorschrijven====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_redenvanvoorschrijven_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_redenvanvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T om 15:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T - 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatie gebruik stop type
|style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T - 2 dagen, geneesmiddel niet in gebruik, tijdelijk gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden wijzigen of stoppen gebruik
|style="background-color: white;"|verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset2-v20-2-3 /><section end=mg-mp-mg-tst-MGB-Scenarioset2-v20-2-3 />
== TEST Medicatiegegevens MGB Scenarioset 5==
<section begin=mg-mp-mg-tst-MGB-Scenarioset5-v20-5-1 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rozendal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900985 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|11 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-1 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-1 />
==== Scenario 5.1 - MBH_200_volgens_afspraak====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_volgens_afspraak_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_volgens_afspraak_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 5 dagen om 18:20:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PRADAXA CAPSULE 110MG (code = '1929461' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '86991' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|DABIGATRAN ETEXILAAT CAPSULE 110MG (code = '129720' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 10 dagen, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-1 /><section end=mg-mp-mg-tst-MGB-Scenarioset5-v20-5-1 />
== TEST Medicatiegegevens MGB Scenarioset 5==
<section begin=mg-mp-mg-tst-MGB-Scenarioset5-v20-5-2 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rozendal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900985 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|11 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-2 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-2 />
==== Scenario 5.2 - MBH_200_niet_volgens_afspraak====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_niet_volgens_afspraak_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_niet_volgens_afspraak_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 19 dagen om 10:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen, tot en met T - 20 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|SIMVASTATINE TABLET FO 20MG (code = '67814' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SIMVASTATINE TABLET FO 20MG (code = '116580' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 30 dagen, tot en met T - 20 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_niet_volgens_afspraak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-2 /><section end=mg-mp-mg-tst-MGB-Scenarioset5-v20-5-2 />
== TEST Medicatiegegevens MGB Scenarioset 5==
<section begin=mg-mp-mg-tst-MGB-Scenarioset5-v20-5-3 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rozendal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900985 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|11 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-3 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-3 />
==== Scenario 5.3 - MBH_200_geen_gebruik_niet_volgens_afspraak====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_geen_gebruik_niet_volgens_afspraak_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_geen_gebruik_niet_volgens_afspraak_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 4 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 6 dagen, tot en met T - 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 6 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatie gebruik stop type
|style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|HYDROCHLOORTHIAZIDE APOTEX TABLET 12,5MG (code = '2530104' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 6 dagen, tot en met T - 5 dagen, geneesmiddel niet in gebruik, tijdelijk gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_geen_gebruik_niet_volgens_afspraak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_geen_gebruik_niet_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-3 /><section end=mg-mp-mg-tst-MGB-Scenarioset5-v20-5-3 />
== TEST Medicatiegegevens MGB Scenarioset 5==
<section begin=mg-mp-mg-tst-MGB-Scenarioset5-v20-5-4 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rozendal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900985 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|11 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-4 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-4 />
==== Scenario 5.4 - MBH_200_geen_gebruik_volgens_afspraak====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_geen_gebruik_volgens_afspraak_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_geen_gebruik_volgens_afspraak_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 10 dagen om 12:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatie gebruik stop type
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '76333' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|HYDROCHLOORTHIAZIDE TABLET 12,5MG (code = '122602' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 19 dagen, geneesmiddel niet in gebruik, definitief gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_geen_gebruik_volgens_afspraak_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_geen_gebruik_volgens_afspraak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-4 /><section end=mg-mp-mg-tst-MGB-Scenarioset5-v20-5-4 />
== TEST Medicatiegegevens MGB Scenarioset 5==
<section begin=mg-mp-mg-tst-MGB-Scenarioset5-v20-5-5 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rozendal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900985 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|11 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-5 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-5 />
==== Scenario 5.5 - MBH_200_zelfzorgmedicatie====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_zelfzorgmedicatie_MBG
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_zelfzorgmedicatie_MBG (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 80 dagen om 20:30:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 90 dagen, gedurende 10 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 90 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PREVALIN ALLERSTOP CETIRIZINE TABLET FILMOMH 10MG (code = '2497905' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|CETIRIZINE TABLET 10MG (code = '26298' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|CETIRIZINE TABLET 10MG (code = '71218' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 90 dagen, gedurende 10 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_zelfzorgmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="" width="25%"| Gegevenselement
|| Waarde

|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset5-v20-5-5 /><section end=mg-mp-mg-tst-MGB-Scenarioset5-v20-5-5 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-1 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-1 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-1 />
==== Scenario 6.1 - MBH_200_variabelefrequentie====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_variabelefrequentie_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_variabelefrequentie_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 16 dagen om 16:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 16 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 à 2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_variabelefrequentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-1 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-1 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-2 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-2 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-2 />
==== Scenario 6.2 - MBH_200_interval====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_interval_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_interval_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 16 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 16 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, iedere 8 uur 1 stuk - let op, tijden exact aanhouden, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|iedere 8 uur 1 stuk - let op, tijden exact aanhouden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-2 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-2 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-3 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-3 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-3 />
==== Scenario 6.3 - MBH_200_variabelehoeveelheid====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_variabelehoeveelheid_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 14 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, 3 maal per dag 1 à 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 à 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-3 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-3 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-4 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-4 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-4 />
==== Scenario 6.4 - MBH_200_zonderkeerdosis====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_zonderkeerdosis_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_zonderkeerdosis_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 21 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, 3 maal per dag, aanbrengen, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-4 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-4 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-5 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-5 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-5 />
==== Scenario 6.5 - MBH_200_bijzonderekeerdosis====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_bijzonderekeerdosis_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_bijzonderekeerdosis_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 14 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, 2 maal per dag 0.5 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 0.5 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-5 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-5 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-6 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-6 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-6 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-6 />
==== Scenario 6.6 - MBH_200_variabelehoeveelheid2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_variabelehoeveelheid2_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid2_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 21 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 10 à 15 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-6 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-6 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7a /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7a />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7a /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7a />
==== Scenario 6.7a - MBH_200_tijdstippen_flexibel====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_tijdstippen_flexibel_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_tijdstippen_flexibel_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 14 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7a /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7a />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7b /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7b />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7b /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7b />
==== Scenario 6.7b - MBH_200_tijdstippen_niet_flexibel====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_tijdstippen_niet_flexibel_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 7 dagen om 16:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen om 15:00 uur''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 7 dagen om 15:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 7 dagen om 15:00 uur, elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, tijden exact aanhouden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, tijden exact aanhouden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7b /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-7b />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-8 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-8 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-8 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-8 />
==== Scenario 6.8 - MBH_200_weekdagen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_weekdagen_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_weekdagen_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 14 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|op maandag, woensdag en vrijdag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-8 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-8 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-9 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-9 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-9 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-9 />
==== Scenario 6.9 - MBH_200_dagdeel====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_dagdeel_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_dagdeel_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 14 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, 1 stuk 's avonds, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 stuk 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-9 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-9 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-10 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-10 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-10 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-10 />
==== Scenario 6.10 - MBH_200_cyclischschema====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_cyclischschema_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_cyclischschema_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 14 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Herhaalperiode cyclisch schema
|style="background-color: white;"|28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-10 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-10 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-11 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-11 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-11 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-11 />
==== Scenario 6.11 - MBH_200_afbouwschema====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_afbouwschema_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_afbouwschema_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 21 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 1
|style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 3
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-11 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-11 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-12 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-12 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-12 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-12 />
==== Scenario 6.12 - MBH_200_variabelehoeveelheidenmaximum====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_variabelehoeveelheidenmaximum_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 21 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-12 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-12 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-13 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-13 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-13 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-13 />
==== Scenario 6.13 - MBH_200_toedieningssnelheid====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_toedieningssnelheid_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_toedieningssnelheid_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 8 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 8 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur, parenteraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-13 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-13 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-14 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-14 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-14 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-14 />
==== Scenario 6.14 - MBH_200_toedieningsduur====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_toedieningsduur_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_toedieningsduur_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 14 dagen om 12:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen om 12:00 uur''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen om 12:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen om 12:00 uur, 1 maal per dag 1 stuk gedurende 16 uur, transdermaal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-14 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-14 />
== TEST Medicatiegegevens MGB Scenarioset 6==
<section begin=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-15 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-15 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-15 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-15 />
==== Scenario 6.15 - MBH_200_zonodig====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_zonodig_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_zonodig_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T + 14 dagen om 23:59:59 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset6-v20-6-15 /><section end=mg-mp-mg-tst-MGB-Scenarioset6-v20-6-15 />
== TEST Medicatiegegevens MGB Scenarioset 7==
<section begin=mg-mp-mg-tst-MGB-Scenarioset7-v20-7-1 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-1 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-1 />
==== Scenario 7.1 - MBH_200_magistraalalleingredienten====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_200_magistraalalleingredienten_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraalalleingredienten_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T om 21:53 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="11"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T, 2 maal per dag, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|2 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_magistraalalleingredienten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-1 /><section end=mg-mp-mg-tst-MGB-Scenarioset7-v20-7-1 />
== TEST Medicatiegegevens MGB Scenarioset 7==
<section begin=mg-mp-mg-tst-MGB-Scenarioset7-v20-7-2 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-2 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-2 />
==== Scenario 7.2 - MBH_200_magistraalactieveingredient====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_200_magistraalactieveingredient_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraalactieveingredient_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T om 22:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Nee
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T, 3 maal per dag, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|3 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_magistraalactieveingredient_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-2 /><section end=mg-mp-mg-tst-MGB-Scenarioset7-v20-7-2 />
== TEST Medicatiegegevens MGB Scenarioset 7==
<section begin=mg-mp-mg-tst-MGB-Scenarioset7-v20-7-3 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-3 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-3 />
==== Scenario 7.3 - MBH_200_magistraal90miljoennr====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_200_magistraal90miljoennr_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraal90miljoennr_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatiegebruik datum tijd
|style="background-color: white;"|T om 23:01 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="8"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product code
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_magistraal90miljoennr_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset7-v20-7-3 /><section end=mg-mp-mg-tst-MGB-Scenarioset7-v20-7-3 />
== TEST Medicatiegegevens MGB Scenarioset 10==
<section begin=mg-mp-mg-tst-MGB-Scenarioset10-v20-10-1 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|J.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Bree
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901588 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jul 2010
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-1 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-1 />
==== Scenario 10.1 - MBH_200_HPKvoorschrijven====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_HPKvoorschrijven_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_HPKvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T om 22:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_HPKvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-1 /><section end=mg-mp-mg-tst-MGB-Scenarioset10-v20-10-1 />
== TEST Medicatiegegevens MGB Scenarioset 10==
<section begin=mg-mp-mg-tst-MGB-Scenarioset10-v20-10-2 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|J.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Bree
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901588 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jul 2010
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-2 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-2 />
==== Scenario 10.2 - MBH_200_ZINRvoorschrijven====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_ZINRvoorschrijven_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T om 22:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Auteur is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie toedieningsafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset10-v20-10-2 /><section end=mg-mp-mg-tst-MGB-Scenarioset10-v20-10-2 />
== TEST Medicatiegegevens MGB Scenarioset 13==
<section begin=mg-mp-mg-tst-MGB-Scenarioset13-v20-13-5 /><section begin=patient-mg-mp-mg-tst-MGB-Scenarioset13-v20-13-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Smitsz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901072 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|19 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MGB-Scenarioset13-v20-13-5 /><section begin=mbhs-mg-mp-mg-tst-MGB-Scenarioset13-v20-13-5 />
==== Scenario 13.5 - MBH_200_contactepisode====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatiegebruik MBH_200_contactepisode_MGB
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_contactepisode_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatiegebruik datum tijd
|style="background-color: white;"|T - 10 dagen om 09:56:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruik indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Volgens afspraak indicator
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Informant
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Informant is patient
|style="background-color: white;"|Ja
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T - 9 dagen, 1 maal per dag 2 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_contactepisode_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie contact
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatienummer
|style="background-color: white;"|MBH_200_contactepisode_CONTACT3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.2709)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie zorgepisode
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatienummer
|style="background-color: white;"|MBH_200_contactepisode_EPISODE1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.66.9200)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_contactepisode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MGB-Scenarioset13-v20-13-5 /><section end=mg-mp-mg-tst-MGB-Scenarioset13-v20-13-5 />

[[Categorie:Kwalificatie]]

mp:V2.0.0 testgegevens medicatiegegevens raadplegen MVE

2022-11-17T11:45:10Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens raadplegend systeem (MVE)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''R'''aadplegend systeem (MP-MGR) '''medicatieverstrekking'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : email adres volgt

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Stuur voor de genoemde patiënt het 'Medicatiegegevens raadplegen' bericht.
# De simulator verstuurt een 'Medicatiegegevens beschikbaarstellen' bericht met inhoudelijke gegevens.
# Verwerk dit bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier ontvangt als medicatiegegevens raadplegend systeem. Dit zijn de gegevens voor medicatieverstrekking.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

== Scenarioset 0: filtercriteria ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-0}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-1}}

<br>

== Scenarioset 1: verstrekkingen - extra MVE ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-1}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset1-v20-1-1}}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset1-v20-1-1}}

<br>

== Scenarioset 2: verstrekking basale inhoud - andere elementen ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-2}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-2 }}
<br>
<br>
<br>
<br>

== Scenarioset 3 ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-3}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset3-v20-3-2 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset3-v20-3-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset3-v20-3-5}}

<br>
<br>

== Scenarioset 4 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 5 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 6 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 7: verstrekkingen met magistraal/eigen artikel ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-7}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-3}}

<br>
<br>

== Scenarioset 8: andermans verstrekking ==
Nog niet van toepassing.
<br>
<br>

== Scenarioset 9: verstrekking overige elementen ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-9}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1b }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1b}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1c}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-3}}

<br>

== Scenarioset 10: verstrekking o.b.v. ZI-nr ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-10}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset10-v20-10-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset10-v20-10-1}}
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens medicatieverstrekking addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens beschikbaarstellen MVE

2022-11-17T11:44:43Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens beschikbaarstellend systeem (MVE)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''B'''eschikbaarstellend systeem (MP-MGB) '''medicatieverstrekking'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : email adres volgt

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Voer de gegevens van alle te testen medicatieverstrekkingen in voor de persoon genoemd in Persoonsgegevens.
# De simulator verstuurt een 'Medicatiegegevens raadplegen' bericht.
# Ontvang het 'Medicatiegegevens raadplegen' bericht en beantwoord deze met een 'Medicatiegegevens beschikbaarstellen' bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier beschikbaar moet stellen als medicatiegegevens beschikbaarstellend systeem. Dit zijn de gegevens voor medicatieverstrekking.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

=== Beschikbaarstellend systeem===
Het beschikbaarstellend systeem voert de gegevens uit de paragrafen "Inhoudelijke gegevens" in het XIS in. Voor een beschikbaarstellend systeem geldt dat sommige gegevens door dit systeem bepaald mogen of moeten worden:

* Zorgverlener, zorgaanbieder (denk aan verstrekker, voorschrijver). Dit mag een eigen (test)zorgverlener en organisatie zijn.
* Identificatie van medicamenteuze behandeling, medicatiebouwstenen (medicatieverstrekking). LET OP: verwacht wordt dat hier 'eigen' identificaties aan worden toegekend in een eigen identificatiesysteem (eigen OID). De onderlinge referenties moeten natuurlijk wel kloppen (dus een toedieningsafspraak en een medicatieverstrekking blijven horen bij dezelfde medicamenteuze behandeling als de medicatieafspraak en verstrekkingsverzoek vanuit de voorschrijver). De identificatie van medicamenteuze behandeling mag niet door het beschikbaarstellend systeem bepaald worden indien het aanpassingen (of aanvullende bouwstenen) betreft op andermans medicamenteuze behandeling.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

== Scenarioset 0: filtercriteria ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-0}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-1}}

<br>

== Scenarioset 1: verstrekkingen - extra MVE ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-1}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset1-v20-1-1}}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset1-v20-1-1}}

<br>

== Scenarioset 2: verstrekking basale inhoud - andere elementen ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-2}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-2 }}
<br>
<br>
<br>
<br>

== Scenarioset 3 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 4 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 5 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 6 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 7: verstrekkingen met magistraal/eigen artikel ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-7}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-3}}

<br>
<br>

== Scenarioset 8: andermans verstrekking ==
Nog niet van toepassing.
<br>
<br>

== Scenarioset 9: verstrekking overige elementen ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-9}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1b }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1b}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1c}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-3}}

<br>

== Scenarioset 10: verstrekking o.b.v. ZI-nr ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|overview-MGR-10}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|patient-mg-mp-mg-tst-MVE-Scenarioset10-v20-10-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|mbhs-mg-mp-mg-tst-MVE-Scenarioset10-v20-10-1}}
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_MVE_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens medicatieverstrekking addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens MVE addendum

2022-11-17T11:43:29Z

Tim Schuller:

__NUMBEREDHEADINGS__
{{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens 9 2.0 - MVE: addendum inhoudelijke gegevens kwalificatie}}

=Addenda voor inhoudelijke gegevens=
== Overzicht van scenario's voor sturend/beschikbaarstellend systeem ==

=== Scenarioset 0===
<section begin=overview-MGB-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| || Alle verstrekkingen van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 6 verstrekkingen)
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| || <div>Specifieke verstrekking met identificaties als filter (in kwalificatiesimulator het id van "MBH_200_QA1_MVE" invoeren) (Antwoord: bericht met 1 verstrekking)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.3 optioneel|| || <div>Verstrekkingen met een filter op productcode (PRK 3956) (Antwoord: bericht met 1 verstrekking)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| || <div>Verstrekking met een filter op verstrekkingsperiode – ingangsdatum (alles vanaf T-21) (Antwoord: bericht met 3 verstrekkingen)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| || <div>Verstrekkingen met een filter op verstrekkingsperiode – einddatum (alles voor T-22) (Antwoord: bericht met 3 verstrekkingen)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.6|| || <div>Verstrekkingen met een filter op verstrekkingsperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7) (Antwoord: bericht met 2 verstrekkingen)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.7|| || <div>Verstrekkingen met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_200_QA1" invoeren) (Antwoord: bericht met 1 verstrekking)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.8|| || <div>Een antwoord zonder verstrekking (filter op verstrekkingsperiode – einddatum (alles voor T-110)) (Antwoord: bericht zonder verstrekking)</div>
|}
<section end=overview-MGB-0 />
=== Scenarioset 1===
<section begin=overview-MGB-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id
|-style="vertical-align:top;|style="background-color: white;"
|1.1|| || <div>Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie)</div>|| MBH_200_chronisch|| MBH_200_chronisch_MVE<br/>MBH_200_chronisch_MVE_extraMVEbestaandeTA
|}
<section end=overview-MGB-1 />
=== Scenarioset 2===
<section begin=overview-MGB-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_200_toelichting|| MBH_200_toelichting_MVE
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' zichtbaar is|| Aanvullende informatie|| MBH_200_aanvullendeinformatiewensen|| MBH_200_aanvullendeinformatiewensen_MVE
|}
<section end=overview-MGB-2 />
=== Scenarioset 7===
<section begin=overview-MGB-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id
|-style="vertical-align:top;|style="background-color: white;"
|7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_200_magistraalalleingredienten|| MBH_200_magistraalalleingredienten_MVE
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_200_magistraalactieveingredient|| MBH_200_magistraalactieveingredient_MVE
|-style="vertical-align:top;|style="background-color: white;"
|7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_200_magistraal90miljoennr|| MBH_200_magistraal90miljoennr_MVE
|}
<section end=overview-MGB-7 />
=== Scenarioset 9===
<section begin=overview-MGB-9 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id
|-style="vertical-align:top;|style="background-color: white;"
|9.1b|| || GDS|| MBH_200_logistiekeverbruiksperiode_eind|| MBH_200_logistiekeverbruiksperiode_eind_MVE
|-style="vertical-align:top;|style="background-color: white;"
|9.1c|| || Verbruiksduur|| MBH_200_logistiekeverbruiksperiode_duur_dagen|| MBH_200_logistiekeverbruiksperiode_duur_dagen_MVE
|-style="vertical-align:top;|style="background-color: white;"
|9.3|| Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden|| Afleverlocatie en aanschrijfdatum|| MBH_200_afleverlocatie|| MBH_200_afleverlocatie_MVE
|}
<section end=overview-MGB-9 />
=== Scenarioset 10===
<section begin=overview-MGB-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| || ZI-nr geneesmiddel|| MBH_200_ZINRvoorschrijven|| MBH_200_ZINRvoorschrijven_MVE
|}
<section end=overview-MGB-10 />
== Overzicht van scenario's voor ontvangend/raadplegend systeem ==

=== Scenarioset 0===
<section begin=overview-MGR-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| Alle verstrekkingen van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 6 verstrekkingen)
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| <div>Specifieke verstrekking met identificaties als filter (in kwalificatiesimulator het id van "MBH_200_QA1_MVE" invoeren) (Antwoord: bericht met 1 verstrekking)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.3|| <div>Verstrekkingen met een filter op productcode (PRK 3956) (Antwoord: bericht met 1 verstrekking)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| <div>Verstrekking met een filter op verstrekkingsperiode – ingangsdatum (alles vanaf T-21) (Antwoord: bericht met 3 verstrekkingen)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| <div>Verstrekkingen met een filter op verstrekkingsperiode – einddatum (alles voor T-22) (Antwoord: bericht met 3 verstrekkingen)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.6|| <div>Verstrekkingen met een filter op verstrekkingsperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7) (Antwoord: bericht met 2 verstrekkingen)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.7|| <div>Verstrekkingen met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_200_QA1" invoeren) (Antwoord: bericht met 1 verstrekking)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.8|| <div>Een antwoord zonder verstrekking (filter op verstrekkingsperiode – einddatum (alles voor T-110)) (Antwoord: bericht zonder verstrekking)</div>
|}
<section end=overview-MGR-0 />
=== Scenarioset 1===
<section begin=overview-MGR-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MVE id
|-style="vertical-align:top;|style="background-color: white;"
|1.1|| <div>Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie)</div>|| MBH_200_chronisch|| MBH_200_chronisch_MVE<br/>MBH_200_chronisch_MVE_extraMVEbestaandeTA
|}
<section end=overview-MGR-1 />
=== Scenarioset 2===
<section begin=overview-MGR-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MVE id
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| Toelichting|| MBH_200_toelichting|| MBH_200_toelichting_MVE
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Aanvullende informatie|| MBH_200_aanvullendeinformatiewensen|| MBH_200_aanvullendeinformatiewensen_MVE
|}
<section end=overview-MGR-2 />
=== Scenarioset 7===
<section begin=overview-MGR-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MVE id
|-style="vertical-align:top;|style="background-color: white;"
|7.1|| Alle ingrediënten|| MBH_200_magistraalalleingredienten|| MBH_200_magistraalalleingredienten_MVE
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| Actief ingrediënt|| MBH_200_magistraalactieveingredient|| MBH_200_magistraalactieveingredient_MVE
|-style="vertical-align:top;|style="background-color: white;"
|7.3|| 90 miljoen nummer|| MBH_200_magistraal90miljoennr|| MBH_200_magistraal90miljoennr_MVE
|}
<section end=overview-MGR-7 />
=== Scenarioset 9===
<section begin=overview-MGR-9 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MVE id
|-style="vertical-align:top;|style="background-color: white;"
|9.1b|| GDS|| MBH_200_logistiekeverbruiksperiode_eind|| MBH_200_logistiekeverbruiksperiode_eind_MVE
|-style="vertical-align:top;|style="background-color: white;"
|9.1c|| Verbruiksduur|| MBH_200_logistiekeverbruiksperiode_duur_dagen|| MBH_200_logistiekeverbruiksperiode_duur_dagen_MVE
|-style="vertical-align:top;|style="background-color: white;"
|9.3|| Afleverlocatie en aanschrijfdatum|| MBH_200_afleverlocatie|| MBH_200_afleverlocatie_MVE
|}
<section end=overview-MGR-9 />
=== Scenarioset 10===
<section begin=overview-MGR-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MVE id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| ZI-nr geneesmiddel|| MBH_200_ZINRvoorschrijven|| MBH_200_ZINRvoorschrijven_MVE
|}
<section end=overview-MGR-10 />
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-1 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-1 />
==== Scenario 0.1 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA1_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|60 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA1_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA2_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 100 dagen om 09:04 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|300 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA2_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA3_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 50 dagen om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|4000 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA3_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA4_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 10 dagen om 09:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA4_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA5====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA5_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA5_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 50 dagen om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|56 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA5_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA6====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA6_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA6_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 5 dagen om 09:18 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|21 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA6_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-1 />
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-2 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-2 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-2 />
==== Scenario 0.2 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA1_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|60 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA1_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-2 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-2 />
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-3optioneel /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-3optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-3optioneel /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-3optioneel />
==== Scenario 0.3 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA4_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 10 dagen om 09:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA4_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-3optioneel /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-3optioneel />
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-4 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-4 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-4 />
==== Scenario 0.4 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA1_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|60 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA1_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA4_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 10 dagen om 09:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA4_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_200_QA6====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA6_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA6_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 5 dagen om 09:18 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|21 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA6_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-4 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-4 />
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-5 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-5 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-5 />
==== Scenario 0.5 - MBH_200_QA2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA2_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 100 dagen om 09:04 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|300 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA2_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.5 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA3_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 50 dagen om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|4000 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA3_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.5 - MBH_200_QA5====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA5_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA5_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 50 dagen om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|56 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA5_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-5 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-5 />
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-6 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-6 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-6 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-6 />
==== Scenario 0.6 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA1_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|60 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA1_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.6 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA4_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 10 dagen om 09:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA4_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-6 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-6 />
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-7 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-7 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-7 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-7 />
==== Scenario 0.7 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_QA1_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|60 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_QA1_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-7 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-7 />
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-8 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-8 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-8 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-8 /><section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v20-0-8 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v20-0-8 />
== TEST Medicatiegegevens MVE Scenarioset 1==
<section begin=mg-mp-mg-tst-MVE-Scenarioset1-v20-1-1 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset1-v20-1-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset1-v20-1-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset1-v20-1-1 />
==== Scenario 1.1 - MBH_200_chronisch====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_chronisch_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_chronisch_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 30 dagen om 12:32 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|21 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_chronisch_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_chronisch_MVE_extraMVEbestaandeTA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_chronisch_MVE_extraMVEbestaandeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 10 dagen om 12:35 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|90 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_chronisch_VV_extraVVbestaandeMA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset1-v20-1-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset1-v20-1-1 />
== TEST Medicatiegegevens MVE Scenarioset 2==
<section begin=mg-mp-mg-tst-MVE-Scenarioset2-v20-2-1 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-1 />
==== Scenario 2.1 - MBH_200_toelichting====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_toelichting_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_toelichting_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 21 dagen om 09:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toelichting
|style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_toelichting_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset2-v20-2-1 />
== TEST Medicatiegegevens MVE Scenarioset 2==
<section begin=mg-mp-mg-tst-MVE-Scenarioset2-v20-2-2 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-2 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-2 />
==== Scenario 2.2 - MBH_200_aanvullendeinformatiewensen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_aanvullendeinformatiewensen_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 5 dagen om 09:06 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v20-2-2 /><section end=mg-mp-mg-tst-MVE-Scenarioset2-v20-2-2 />
== TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset7-v20-7-1 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-1 />
==== Scenario 7.1 - MBH_200_magistraalalleingredienten====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_200_magistraalalleingredienten_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraalalleingredienten_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T om 13:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|style="background-color: white;"|100 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="11"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_magistraalalleingredienten_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset7-v20-7-1 />
== TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset7-v20-7-2 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-2 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-2 />
==== Scenario 7.2 - MBH_200_magistraalactieveingredient====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_200_magistraalactieveingredient_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraalactieveingredient_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T om 13:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|style="background-color: white;"|100 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_magistraalactieveingredient_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-2 /><section end=mg-mp-mg-tst-MVE-Scenarioset7-v20-7-2 />
== TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset7-v20-7-3 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-3 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-3 />
==== Scenario 7.3 - MBH_200_magistraal90miljoennr====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_200_magistraal90miljoennr_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraal90miljoennr_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T om 13:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekte hoeveelheid
|style="background-color: white;"|100 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="8"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product code
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_magistraal90miljoennr_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v20-7-3 /><section end=mg-mp-mg-tst-MVE-Scenarioset7-v20-7-3 />
== TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1b /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1b />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Tewarie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900961 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|9 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1b /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1b />
==== Scenario 9.1b - MBH_200_logistiekeverbruiksperiode_eind====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_logistiekeverbruiksperiode_eind_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_eind_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T - 9 dagen om 12:01 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|100 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Distributievorm
|style="background-color: white;"|GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_eind_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1b /><section end=mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1b />
== TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1c /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1c />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Tewarie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900961 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|9 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1c /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1c />
==== Scenario 9.1c - MBH_200_logistiekeverbruiksperiode_duur_dagen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_logistiekeverbruiksperiode_duur_dagen_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_duur_dagen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T om 12:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|100 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verbruiksduur
|style="background-color: white;"|50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_duur_dagen_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1c /><section end=mg-mp-mg-tst-MVE-Scenarioset9-v20-9-1c />
== TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset9-v20-9-3 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Tewarie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900961 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|9 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-3 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-3 />
==== Scenario 9.3 - MBH_200_afleverlocatie====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_afleverlocatie_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_afleverlocatie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T om 12:07 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aanschrijf datum
|style="background-color: white;"|T om 11:07 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Afleverlocatie
|style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_afleverlocatie_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v20-9-3 /><section end=mg-mp-mg-tst-MVE-Scenarioset9-v20-9-3 />
== TEST Medicatiegegevens MVE Scenarioset 10 (ZI)==
<section begin=mg-mp-mg-tst-MVE-Scenarioset10-v20-10-1 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset10-v20-10-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|J.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Bree
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901588 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jul 2010
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset10-v20-10-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset10-v20-10-1 />
==== Scenario 10.1 - MBH_200_ZINRvoorschrijven====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_200_ZINRvoorschrijven_MVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieverstrekkings datum tijd
|style="background-color: white;"|T om 14:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekte hoeveelheid
|style="background-color: white;"|150 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie verstrekkingsverzoek
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_VV
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset10-v20-10-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset10-v20-10-1 />

[[Categorie:Kwalificatie]]

mp:V2.0.0 testgegevens medicatiegegevens raadplegen TA

2022-11-17T11:40:56Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens raadplegend systeem (TA)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''R'''aadplegend systeem (MP-MGR) '''toedieningsafspraak'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Stuur voor de genoemde patiënt het 'Medicatiegegevens raadplegen' bericht.
# De simulator verstuurt een 'Medicatiegegevens beschikbaarstellen' bericht met inhoudelijke gegevens.
# Verwerk dit bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier ontvangt als medicatiegegevens raadplegend systeem. Dit zijn de gegevens voor toedieningsafspraak.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

==Scenarioset 0: filtercriteria==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-0 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-1 }}
<br>
<br>
<br>

== Scenarioset 1: toedieningsafspraak basale inhoud - gebruiksperiode ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-1 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset1-v20-1-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-2a }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-2b }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-4 }}
<br>
<br>
<br>

== Scenarioset 2: toedieningsafspraak basale inhoud - andere elementen ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-2 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset2-v20-2-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-4 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-5 }}
<br>
<br>
<br>

== Scenarioset 3: stop-toedieningsafspraken (staken, wijzigen, onderbreken) ==
=== Scenario’s ===

<font color=#FF0000>LET OP: onderstaande scenario's bevatten toedieningsafspraken welke gestopt (tijdelijk/definitief) of gewijzigd zijn.</font>
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-3 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset3-v20-3-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-4 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-5 }}
<br>
<br>
<br>

== Scenarioset 4 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 5 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 6: toedieningsafspraken met diverse doseerschema's ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-6 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-4 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-5 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-6 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-7a }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-7b }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-8 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-9 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-10 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-11 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-12 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-13 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-14 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-15 }}
<br>
<br>
<br>

== Scenarioset 7: toedieningsafspraken met magistraal/eigen artikel ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-7 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset7-v20-7-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7-v20-7-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7-v20-7-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7-v20-7-3 }}
<br>
<br>
<br>

== Scenarioset 8: andermans toedieningsafspraak ==
Nog niet van toepassing.
<br>
<br>

== Scenarioset 9 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 10: toedieningsafspraak o.b.v. ZI-nr ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-10 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset10-v20-10-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset10-v20-10-1 }}

<br>
<br>
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens toedieningsafspraak addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens beschikbaarstellen TA

2022-11-17T11:40:09Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens beschikbaarstellend systeem (TA)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''B'''eschikbaarstellend systeem (MP-MGB) '''toedieningsafspraak'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Voer de gegevens van alle te testen toedieningsafspraken in voor de persoon genoemd in Persoonsgegevens.
# De simulator verstuurt een 'Medicatiegegevens raadplegen' bericht.
# Ontvang het 'Medicatiegegevens raadplegen' bericht en beantwoord deze met een 'Medicatiegegevens beschikbaarstellen' bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier beschikbaar moet stellen als medicatiegegevens beschikbaarstellend systeem. Dit zijn de gegevens voor toedieningsafspraak.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

=== Beschikbaarstellend systeem===
Het beschikbaarstellend systeem voert de gegevens uit de paragrafen "Inhoudelijke gegevens" in het XIS in. Voor een beschikbaarstellend systeem geldt dat sommige gegevens door dit systeem bepaald mogen of moeten worden:

* Zorgverlener, zorgaanbieder (denk aan verstrekker, voorschrijver). Dit mag een eigen (test)zorgverlener en organisatie zijn.
* Identificatie van medicamenteuze behandeling, medicatiebouwstenen (toedieningsafspraak). LET OP: verwacht wordt dat hier 'eigen' identificaties aan worden toegekend in een eigen identificatiesysteem (eigen OID). De onderlinge referenties moeten natuurlijk wel kloppen (dus een toedieningsafspraak en een medicatieverstrekking blijven horen bij dezelfde medicamenteuze behandeling als de medicatieafspraak en verstrekkingsverzoek vanuit de voorschrijver). De identificatie van medicamenteuze behandeling mag niet door het beschikbaarstellend systeem bepaald worden indien het aanpassingen (of aanvullende bouwstenen) betreft op andermans medicamenteuze behandeling.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

==Scenarioset 0: filtercriteria==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-0 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-1 }}
<br>
<br>
<br>

== Scenarioset 1: toedieningsafspraak basale inhoud - gebruiksperiode ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-1 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset1-v20-1-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-2a }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-2b }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-4 }}
<br>
<br>
<br>

== Scenarioset 2: toedieningsafspraak basale inhoud - andere elementen ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-2 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset2-v20-2-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-4 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-5 }}
<br>
<br>
<br>

== Scenarioset 3: stop-toedieningsafspraken (staken, wijzigen, onderbreken) ==
=== Scenario’s ===

<font color=#FF0000>LET OP: onderstaande scenario's bevatten toedieningsafspraken welke gestopt (tijdelijk/definitief) of gewijzigd zijn.</font>
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-3 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset3-v20-3-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-4 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-5 }}
<br>
<br>
<br>

== Scenarioset 4 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 5 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 6: toedieningsafspraken met diverse doseerschema's ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-6 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-4 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-5 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-6 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-7a }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-7b }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-8 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-9 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-10 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-11 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-12 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-13 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-14 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-15 }}
<br>
<br>
<br>

== Scenarioset 7: toedieningsafspraken met magistraal/eigen artikel ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-7 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset7-v20-7-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7-v20-7-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7-v20-7-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset7-v20-7-3 }}
<br>
<br>
<br>

== Scenarioset 8: andermans toedieningsafspraak ==
Nog niet van toepassing.
<br>
<br>

== Scenarioset 9 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 10: toedieningsafspraak o.b.v. ZI-nr ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|overview-MGR-10 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|patient-mg-mp-mg-tst-TA-Scenarioset10-v20-10-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|mbhs-mg-mp-mg-tst-TA-Scenarioset10-v20-10-1 }}

<br>
<br>
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_TA_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens toedieningsafspraak addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens TA addendum

2022-11-17T11:39:06Z

Tim Schuller:

__NUMBEREDHEADINGS__
{{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens 9 2.0 - TA: addendum inhoudelijke gegevens kwalificatie}}

=Addenda voor inhoudelijke gegevens=
== Overzicht van scenario's voor sturend/beschikbaarstellend systeem ==

=== Scenarioset 0===
<section begin=overview-MGB-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| || <div>Alle toedieningsafspraken van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 6 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| || <div>Specifieke toedieningsafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_200_QA1_TA" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.3 optioneel|| || <div>Toedieningsafspraken met een filter op productcode (PRK 3956) (Antwoord: bericht met 1 toedieningsafspraak)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| || <div>Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21) (Antwoord: bericht met 4 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| || <div>Toedieningsafspraken met een filter op gebruiksperiode – einddatum (alles voor T-22) (Antwoord: bericht met 3 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.6|| || <div>Toedieningafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7) (Antwoord: bericht met 3 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.7|| || <div>Toedieningsafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_200_QA1" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.8|| || <div>Een antwoord zonder toedieningsafspraken (filter op gebruiksperiode – einddatum (alles voor T-110)) (Antwoord: bericht zonder toedieningsafspraken)</div>
|}
<section end=overview-MGB-0 />
=== Scenarioset 1===
<section begin=overview-MGB-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|1.1*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en einddatum</div>|| MBH_200_start_eind|| MBH_200_start_eind_TA
|-style="vertical-align:top;|style="background-color: white;"
|1.2a*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (weken)</div>|| MBH_200_start_duur|| MBH_200_start_duur_TA
|-style="vertical-align:top;|style="background-color: white;"
|1.2b*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)</div>|| MBH_200_start_duur2|| MBH_200_start_duur2_TA
|-style="vertical-align:top;|style="background-color: white;"
|1.3|| || <div>Toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)</div>|| MBH_200_chronisch|| MBH_200_chronisch_TA
|-style="vertical-align:top;|style="background-color: white;"
|1.4|| || <div>Toedieningsafspraak met eenheid 'dosis/stuks'</div>|| MBH_200_dosis_stuks|| MBH_200_dosis_stuks_TA
|}
<section end=overview-MGB-1 />
=== Scenarioset 2===
<section begin=overview-MGB-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje)|| Aanvullende instructie|| MBH_200_aanvullendeinstructie|| MBH_200_aanvullendeinstructie_TA
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_200_toelichting|| MBH_200_toelichting_TA
|-style="vertical-align:top;|style="background-color: white;"
|2.3|| Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld.|| Reden van voorschrijven|| MBH_200_redenvanvoorschrijven|| MBH_200_redenvanvoorschrijven_TA
|-style="vertical-align:top;|style="background-color: white;"
|2.4|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' zichtbaar is|| Aanvullende informatie|| MBH_200_aanvullendeinformatiewensen|| MBH_200_aanvullendeinformatiewensen_TA
|-style="vertical-align:top;|style="background-color: white;"
|2.5|| Maak screenshot(s) waarop de toelichting zichtbaar is|| Toedieningsweg|| MBH_200_Toedieningsweg|| MBH_200_Toedieningsweg_TA
|}
<section end=overview-MGB-2 />
=== Scenarioset 3===
<section begin=overview-MGB-3 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|3.1|| || <div>Stop-toedienafspraak, met reden staken</div>|| MBH_200_stoppen|| MBH_200_stoppen_TA_start<br/>MBH_200_stoppen_TA_staken
|-style="vertical-align:top;|style="background-color: white;"
|3.2|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Wijziging toedieningsafspraak, met reden wijziging<br/>|| MBH_200_wijzigen_verhoging|| MBH_200_wijzigen_verhoging_TA_start<br/>MBH_200_wijzigen_verhoging_TA_wijzigingmetMVE<br/>MBH_200_wijzigen_verhoging_TA_techstaken
|-style="vertical-align:top;|style="background-color: white;"
|3.3|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div>Wijziging toedieningsafspraak, met reden wijziging</div>|| MBH_200_wijzigen_verlaging|| MBH_200_wijzigen_verlaging_TA_start<br/>MBH_200_wijzigen_verlaging_TA_wijzigingzonderMVE<br/>MBH_200_wijzigen_verlaging_TA_techstaken
|-style="vertical-align:top;|style="background-color: white;"
|3.4|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div>Onderbreken toedieningsafspraak </div>|| MBH_200_onderbreken|| MBH_200_onderbreken_TA_start<br/>MBH_200_onderbreken_TA_onderbreken
|-style="vertical-align:top;|style="background-color: white;"
|3.5|| <div><span style="color: #222222; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt</span></div>|| <div><span style="color: #222222; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Tweede MVE ivm TA met nieuwe PRK. </span></div>|| MBH_200_TAwijzigen|| MBH_200_TAwijzigen_TA_start<br/>MBH_200_TAwijzigen_TA_techstaken<br/>MBH_200_TAwijzigen_TA_anderePRK
|}
<section end=overview-MGB-3 />
=== Scenarioset 6===
<section begin=overview-MGB-6 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|6.1|| || Variabele frequentie|| MBH_200_variabelefrequentie|| MBH_200_variabelefrequentie_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.2|| || Interval|| MBH_200_interval|| MBH_200_interval_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.3|| || Variabele hoeveelheid (1)|| MBH_200_variabelehoeveelheid|| MBH_200_variabelehoeveelheid_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.4|| || Zonder keerdosis|| MBH_200_zonderkeerdosis|| MBH_200_zonderkeerdosis_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.5|| || Bijzondere keerdosis|| MBH_200_bijzonderekeerdosis|| MBH_200_bijzonderekeerdosis_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.6|| || Variabele hoeveelheid (2)|| MBH_200_variabelehoeveelheid2|| MBH_200_variabelehoeveelheid2_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.7a|| Maak screenshot(s) waarop zichtbaar is dat tijdstip gekozen kan worden|| Tijdstippen flexibel|| MBH_200_tijdstippen_flexibel|| MBH_200_tijdstippen_flexibel_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.7b|| || Tijdstippen niet flexibel|| MBH_200_tijdstippen_niet_flexibel|| MBH_200_tijdstippen_niet_flexibel_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.8|| Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden|| Weekdagen|| MBH_200_weekdagen|| MBH_200_weekdagen_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.9|| Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden|| Dagdeel|| MBH_200_dagdeel|| MBH_200_dagdeel_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.10|| Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden|| Cyclisch schema|| MBH_200_cyclischschema|| MBH_200_cyclischschema_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.11|| Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden|| Afbouw schema en doseerduur|| MBH_200_afbouwschema|| MBH_200_afbouwschema_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.12|| || Variabele hoeveelheid en maximum|| MBH_200_variabelehoeveelheidenmaximum|| MBH_200_variabelehoeveelheidenmaximum_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.13|| || Toedieningssnelheid|| MBH_200_toedieningssnelheid|| MBH_200_toedieningssnelheid_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.14|| || Toedieningsduur|| MBH_200_toedieningsduur|| MBH_200_toedieningsduur_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.15|| Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid)|| Zo nodig|| MBH_200_zonodig|| MBH_200_zonodig_TA
|}
<section end=overview-MGB-6 />
=== Scenarioset 7===
<section begin=overview-MGB-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_200_magistraalalleingredienten|| MBH_200_magistraalalleingredienten_TA
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_200_magistraalactieveingredient|| MBH_200_magistraalactieveingredient_TA
|-style="vertical-align:top;|style="background-color: white;"
|7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_200_magistraal90miljoennr|| MBH_200_magistraal90miljoennr_TA
|}
<section end=overview-MGB-7 />
=== Scenarioset 10===
<section begin=overview-MGB-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| || ZI-nr geneesmiddel|| MBH_200_ZINRvoorschrijven|| MBH_200_ZINRvoorschrijven_TA
|}
<section end=overview-MGB-10 />
== Overzicht van scenario's voor ontvangend/raadplegend systeem ==

=== Scenarioset 0===
<section begin=overview-MGR-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| <div>Alle toedieningsafspraken van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 6 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| <div>Specifieke toedieningsafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_200_QA1_TA" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.3|| <div>Toedieningsafspraken met een filter op productcode (PRK 3956) (Antwoord: bericht met 1 toedieningsafspraak)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| <div>Toedieningsafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21) (Antwoord: bericht met 4 toedienafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| <div>Toedieningsafspraken met een filter op gebruiksperiode – einddatum (alles voor T-22) (Antwoord: bericht met 3 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.6|| <div>Toedieningafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7) (Antwoord: bericht met 3 toedieningsafspraken)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.7|| <div>Toedieningsafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_200_QA1" invoeren) (Antwoord: bericht met 1 toedieningsafspraak)</div>
|-style="vertical-align:top;|style="background-color: white;"
|0.8|| <div>Een antwoord zonder toedieningsafspraken (filter op gebruiksperiode – einddatum (alles voor T-110)) (Antwoord: bericht zonder toedieningsafspraken)</div>
|}
<section end=overview-MGR-0 />
=== Scenarioset 1===
<section begin=overview-MGR-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|1.1|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en einddatum</div>|| MBH_200_start_eind|| MBH_200_start_eind_TA
|-style="vertical-align:top;|style="background-color: white;"
|1.2a|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (weken)</div>|| MBH_200_start_duur|| MBH_200_start_duur_TA
|-style="vertical-align:top;|style="background-color: white;"
|1.2b|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)</div>|| MBH_200_start_duur2|| MBH_200_start_duur2_TA
|-style="vertical-align:top;|style="background-color: white;"
|1.3|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)</div>|| MBH_200_chronisch|| MBH_200_chronisch_TA
|-style="vertical-align:top;|style="background-color: white;"
|1.4|| <div>Toedieningsafspraak met eenheid 'dosis/stuks'</div>|| MBH_200_dosis_stuks|| MBH_200_dosis_stuks_TA
|}
<section end=overview-MGR-1 />
=== Scenarioset 2===
<section begin=overview-MGR-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| Aanvullende instructie|| MBH_200_aanvullendeinstructie|| MBH_200_aanvullendeinstructie_TA
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Toelichting|| MBH_200_toelichting|| MBH_200_toelichting_TA
|-style="vertical-align:top;|style="background-color: white;"
|2.3|| Reden van voorschrijven|| MBH_200_redenvanvoorschrijven|| MBH_200_redenvanvoorschrijven_TA
|-style="vertical-align:top;|style="background-color: white;"
|2.4|| Aanvullende informatie|| MBH_200_aanvullendeinformatiewensen|| MBH_200_aanvullendeinformatiewensen_TA
|-style="vertical-align:top;|style="background-color: white;"
|2.5|| Toedieningsweg|| MBH_200_Toedieningsweg|| MBH_200_Toedieningsweg_TA
|}
<section end=overview-MGR-2 />
=== Scenarioset 3===
<section begin=overview-MGR-3 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|3.1|| <div>Stop-toedienafspraak, met reden staken</div>|| MBH_200_stoppen|| MBH_200_stoppen_TA_start<br/>MBH_200_stoppen_TA_staken
|-style="vertical-align:top;|style="background-color: white;"
|3.2|| Wijziging toedieningsafspraak, met reden wijziging<br/>|| MBH_200_wijzigen_verhoging|| MBH_200_wijzigen_verhoging_TA_start<br/>MBH_200_wijzigen_verhoging_TA_wijzigingmetMVE<br/>MBH_200_wijzigen_verhoging_TA_techstaken
|-style="vertical-align:top;|style="background-color: white;"
|3.3|| <div>Wijziging toedieningsafspraak, met reden wijziging</div>|| MBH_200_wijzigen_verlaging|| MBH_200_wijzigen_verlaging_TA_start<br/>MBH_200_wijzigen_verlaging_TA_wijzigingzonderMVE<br/>MBH_200_wijzigen_verlaging_TA_techstaken
|-style="vertical-align:top;|style="background-color: white;"
|3.4|| <div>Onderbreken toedieningsafspraak </div>|| MBH_200_onderbreken|| MBH_200_onderbreken_TA_start<br/>MBH_200_onderbreken_TA_onderbreken
|-style="vertical-align:top;|style="background-color: white;"
|3.5|| <div><span style="color: #222222; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Tweede MVE ivm TA met nieuwe PRK. </span></div>|| MBH_200_TAwijzigen|| MBH_200_TAwijzigen_TA_start<br/>MBH_200_TAwijzigen_TA_techstaken<br/>MBH_200_TAwijzigen_TA_anderePRK
|}
<section end=overview-MGR-3 />
=== Scenarioset 6===
<section begin=overview-MGR-6 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|6.1|| Variabele frequentie|| MBH_200_variabelefrequentie|| MBH_200_variabelefrequentie_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.2|| Interval|| MBH_200_interval|| MBH_200_interval_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.3|| Variabele hoeveelheid (1)|| MBH_200_variabelehoeveelheid|| MBH_200_variabelehoeveelheid_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.4|| Zonder keerdosis|| MBH_200_zonderkeerdosis|| MBH_200_zonderkeerdosis_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.5|| Bijzondere keerdosis|| MBH_200_bijzonderekeerdosis|| MBH_200_bijzonderekeerdosis_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.6|| Variabele hoeveelheid (2)|| MBH_200_variabelehoeveelheid2|| MBH_200_variabelehoeveelheid2_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.7a|| Tijdstippen flexibel|| MBH_200_tijdstippen_flexibel|| MBH_200_tijdstippen_flexibel_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.7b|| Tijdstippen niet flexibel|| MBH_200_tijdstippen_niet_flexibel|| MBH_200_tijdstippen_niet_flexibel_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.8|| Weekdagen|| MBH_200_weekdagen|| MBH_200_weekdagen_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.9|| Dagdeel|| MBH_200_dagdeel|| MBH_200_dagdeel_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.10|| Cyclisch schema|| MBH_200_cyclischschema|| MBH_200_cyclischschema_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.11|| Afbouw schema en doseerduur|| MBH_200_afbouwschema|| MBH_200_afbouwschema_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.12|| Variabele hoeveelheid en maximum|| MBH_200_variabelehoeveelheidenmaximum|| MBH_200_variabelehoeveelheidenmaximum_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.13|| Toedieningssnelheid|| MBH_200_toedieningssnelheid|| MBH_200_toedieningssnelheid_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.14|| Toedieningsduur|| MBH_200_toedieningsduur|| MBH_200_toedieningsduur_TA
|-style="vertical-align:top;|style="background-color: white;"
|6.15|| Zo nodig|| MBH_200_zonodig|| MBH_200_zonodig_TA
|}
<section end=overview-MGR-6 />
=== Scenarioset 7===
<section begin=overview-MGR-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|7.1|| Alle ingrediënten|| MBH_200_magistraalalleingredienten|| MBH_200_magistraalalleingredienten_TA
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| Actief ingrediënt|| MBH_200_magistraalactieveingredient|| MBH_200_magistraalactieveingredient_TA
|-style="vertical-align:top;|style="background-color: white;"
|7.3|| 90 miljoen nummer|| MBH_200_magistraal90miljoennr|| MBH_200_magistraal90miljoennr_TA
|}
<section end=overview-MGR-7 />
=== Scenarioset 10===
<section begin=overview-MGR-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| TA id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| ZI-nr geneesmiddel|| MBH_200_ZINRvoorschrijven|| MBH_200_ZINRvoorschrijven_TA
|}
<section end=overview-MGR-10 />
== TEST Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-TA-Scenarioset0-v20-0-1 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-1 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-1 />
==== Scenario 0.1 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA1_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA2_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 100 dagen om 09:04 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 72 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 10 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA3_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA4_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 09:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA5====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA5_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|4 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA6====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA6_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA6_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 09:18 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-1 /><section end=mg-mp-mg-tst-TA-Scenarioset0-v20-0-1 />
== TEST Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-TA-Scenarioset0-v20-0-2 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-2 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-2 />
==== Scenario 0.2 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA1_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-2 /><section end=mg-mp-mg-tst-TA-Scenarioset0-v20-0-2 />
== TEST Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-TA-Scenarioset0-v20-0-3optioneel /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-3optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-3optioneel /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-3optioneel />
==== Scenario 0.3 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA4_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 09:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-3optioneel /><section end=mg-mp-mg-tst-TA-Scenarioset0-v20-0-3optioneel />
== TEST Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-TA-Scenarioset0-v20-0-4 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-4 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-4 />
==== Scenario 0.4 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA1_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA3_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA4_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 09:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_200_QA6====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA6_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA6_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 09:18 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-4 /><section end=mg-mp-mg-tst-TA-Scenarioset0-v20-0-4 />
== TEST Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-TA-Scenarioset0-v20-0-5 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-5 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-5 />
==== Scenario 0.5 - MBH_200_QA2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA2_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 100 dagen om 09:04 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 72 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 10 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.5 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA3_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.5 - MBH_200_QA5====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA5_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA5_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|4 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-5 /><section end=mg-mp-mg-tst-TA-Scenarioset0-v20-0-5 />
== TEST Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-TA-Scenarioset0-v20-0-6 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-6 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-6 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-6 />
==== Scenario 0.6 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA1_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.6 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA3_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.6 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA4_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 09:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-6 /><section end=mg-mp-mg-tst-TA-Scenarioset0-v20-0-6 />
== TEST Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-TA-Scenarioset0-v20-0-7 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-7 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-7 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-7 />
==== Scenario 0.7 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_QA1_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-7 /><section end=mg-mp-mg-tst-TA-Scenarioset0-v20-0-7 />
== TEST Medicatiegegevens TA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-TA-Scenarioset0-v20-0-8 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-8 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset0-v20-0-8 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-8 /><section end=mbhs-mg-mp-mg-tst-TA-Scenarioset0-v20-0-8 /><section end=mg-mp-mg-tst-TA-Scenarioset0-v20-0-8 />
== TEST Medicatiegegevens TA Scenarioset 1==
<section begin=mg-mp-mg-tst-TA-Scenarioset1-v20-1-1 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset1-v20-1-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset1-v20-1-1 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-1 />
==== Scenario 1.1 - MBH_200_start_eind====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_start_eind_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 12:20 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|METOCLOPRAMIDE HCL PCH TABLET 10MG (code = '560308' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-1 /><section end=mg-mp-mg-tst-TA-Scenarioset1-v20-1-1 />
== TEST Medicatiegegevens TA Scenarioset 1==
<section begin=mg-mp-mg-tst-TA-Scenarioset1-v20-1-2a /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset1-v20-1-2a />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset1-v20-1-2a /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-2a />
==== Scenario 1.2a - MBH_200_start_duur====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_start_duur_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_start_duur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 12:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|3 weken
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-2a /><section end=mg-mp-mg-tst-TA-Scenarioset1-v20-1-2a />
== TEST Medicatiegegevens TA Scenarioset 1==
<section begin=mg-mp-mg-tst-TA-Scenarioset1-v20-1-2b /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset1-v20-1-2b />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset1-v20-1-2b /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-2b />
==== Scenario 1.2b - MBH_200_start_duur2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_start_duur2_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_start_duur2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 60 dagen om 12:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-2b /><section end=mg-mp-mg-tst-TA-Scenarioset1-v20-1-2b />
== TEST Medicatiegegevens TA Scenarioset 1==
<section begin=mg-mp-mg-tst-TA-Scenarioset1-v20-1-3 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset1-v20-1-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset1-v20-1-3 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-3 />
==== Scenario 1.3 - MBH_200_chronisch====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_chronisch_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 30 dagen om 12:32 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-3 /><section end=mg-mp-mg-tst-TA-Scenarioset1-v20-1-3 />
== TEST Medicatiegegevens TA Scenarioset 1==
<section begin=mg-mp-mg-tst-TA-Scenarioset1-v20-1-4 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset1-v20-1-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset1-v20-1-4 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-4 />
==== Scenario 1.4 - MBH_200_dosis_stuks====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_dosis_stuks_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_dosis_stuks_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 130 dagen om 12:35 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 130 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 101 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 dosis
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset1-v20-1-4 /><section end=mg-mp-mg-tst-TA-Scenarioset1-v20-1-4 />
== TEST Medicatiegegevens TA Scenarioset 2==
<section begin=mg-mp-mg-tst-TA-Scenarioset2-v20-2-1 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset2-v20-2-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset2-v20-2-1 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-1 />
==== Scenario 2.1 - MBH_200_aanvullendeinstructie====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_aanvullendeinstructie_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_aanvullendeinstructie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 4 maanden om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 8 maanden''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 4 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 8 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 8 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-1 /><section end=mg-mp-mg-tst-TA-Scenarioset2-v20-2-1 />
== TEST Medicatiegegevens TA Scenarioset 2==
<section begin=mg-mp-mg-tst-TA-Scenarioset2-v20-2-2 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset2-v20-2-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset2-v20-2-2 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-2 />
==== Scenario 2.2 - MBH_200_toelichting====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_toelichting_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_toelichting_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 21 dagen om 09:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toelichting
|style="background-color: white;"|In overleg met specialist
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-2 /><section end=mg-mp-mg-tst-TA-Scenarioset2-v20-2-2 />
== TEST Medicatiegegevens TA Scenarioset 2==
<section begin=mg-mp-mg-tst-TA-Scenarioset2-v20-2-3 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset2-v20-2-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset2-v20-2-3 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-3 />
==== Scenario 2.3 - MBH_200_redenvanvoorschrijven====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_redenvanvoorschrijven_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_redenvanvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 13 dagen om 09:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 13 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 5 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per week 5 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-3 /><section end=mg-mp-mg-tst-TA-Scenarioset2-v20-2-3 />
== TEST Medicatiegegevens TA Scenarioset 2==
<section begin=mg-mp-mg-tst-TA-Scenarioset2-v20-2-4 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset2-v20-2-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset2-v20-2-4 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-4 />
==== Scenario 2.4 - MBH_200_aanvullendeinformatiewensen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_aanvullendeinformatiewensen_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 09:06 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak aanvullende informatie
|style="background-color: white;"|Bijwerking besproken
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-4 /><section end=mg-mp-mg-tst-TA-Scenarioset2-v20-2-4 />
== TEST Medicatiegegevens TA Scenarioset 2==
<section begin=mg-mp-mg-tst-TA-Scenarioset2-v20-2-5 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset2-v20-2-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset2-v20-2-5 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-5 />
==== Scenario 2.5 - MBH_200_Toedieningsweg====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_Toedieningsweg_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_Toedieningsweg_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 druppel
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak aanvullende informatie
|style="background-color: white;"|Gebruiksinstructie gegeven
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset2-v20-2-5 /><section end=mg-mp-mg-tst-TA-Scenarioset2-v20-2-5 />
== TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mp-mg-tst-TA-Scenarioset3-v20-3-1 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset3-v20-3-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dongen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900493 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|23 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset3-v20-3-1 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-1 />
==== Scenario 3.1 - MBH_200_stoppen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_stoppen_TA_start
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_stoppen_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 60 dagen om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 220 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 220 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 220 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_stoppen_TA_staken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_stoppen_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 19:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak stop type
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T, 1 maal per dag 1 stuk, Oraal, definitief gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_stoppen_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek Jansen en Co
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-1 /><section end=mg-mp-mg-tst-TA-Scenarioset3-v20-3-1 />
== TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mp-mg-tst-TA-Scenarioset3-v20-3-2 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset3-v20-3-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dongen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900493 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|23 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset3-v20-3-2 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-2 />
==== Scenario 3.2 - MBH_200_wijzigen_verhoging====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_wijzigen_verhoging_TA_start
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 21 dagen om 09:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_wijzigen_verhoging_TA_wijzigingmetMVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging_TA_wijzigingmetMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 2 dagen om 09:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 2 dagen, 1 maal per dag 2 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_wijzigen_verhoging_TA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 2 dagen om 09:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak stop type
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek Jansen en Co
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-2 /><section end=mg-mp-mg-tst-TA-Scenarioset3-v20-3-2 />
== TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mp-mg-tst-TA-Scenarioset3-v20-3-3 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset3-v20-3-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dongen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900493 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|23 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset3-v20-3-3 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-3 />
==== Scenario 3.3 - MBH_200_wijzigen_verlaging====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_wijzigen_verlaging_TA_start
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 13 dagen om 09:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 13 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_wijzigen_verlaging_TA_wijzigingzonderMVE
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging_TA_wijzigingzonderMVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 1 dag, tot en met T + 14 dagen, 1 maal per week 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_wijzigen_verlaging_TA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T - 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 13 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak stop type
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 13 dagen, tot en met T - 2 dagen, 2 maal per week 1 stuk, Oraal, definitief gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek Jansen en Co
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-3 /><section end=mg-mp-mg-tst-TA-Scenarioset3-v20-3-3 />
== TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mp-mg-tst-TA-Scenarioset3-v20-3-4 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset3-v20-3-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dongen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900493 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|23 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset3-v20-3-4 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-4 />
==== Scenario 3.4 - MBH_200_onderbreken====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_onderbreken_TA_start
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_onderbreken_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 09:06 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_onderbreken_TA_onderbreken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_onderbreken_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 19:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T - 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak stop type
|style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_Jansen_en_Co|Zorgaanbieder: Apotheek_Jansen_en_Co]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 dagen, tot en met T - 1 dag, 3 maal per dag 1 stuk, Oraal, tijdelijk gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_onderbreken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_Jansen_en_Co" title="Intern ID = Apotheek_Jansen_en_Co">Zorgaanbieder Apotheek_Jansen_en_Co</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|99901111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek Jansen en Co
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-4 /><section end=mg-mp-mg-tst-TA-Scenarioset3-v20-3-4 />
== TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mp-mg-tst-TA-Scenarioset3-v20-3-5 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset3-v20-3-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dongen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900493 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|23 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset3-v20-3-5 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-5 />
==== Scenario 3.5 - MBH_200_TAwijzigen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_TAwijzigen_TA_start
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_TAwijzigen_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 60 dagen om 12:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_TAwijzigen_TA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_TAwijzigen_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 12:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 51 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 51 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak stop type
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T - 51 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_TAwijzigen_TA_anderePRK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_TAwijzigen_TA_anderePRK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 12:35 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 18 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|18 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak reden wijzigen of staken
|style="background-color: white;"|geneesmiddel niet voorradig (code = '182856006' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 18 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset3-v20-3-5 /><section end=mg-mp-mg-tst-TA-Scenarioset3-v20-3-5 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-1 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-1 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-1 />
==== Scenario 6.1 - MBH_200_variabelefrequentie====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_variabelefrequentie_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_variabelefrequentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 16 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 à 2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-1 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-1 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-2 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-2 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-2 />
==== Scenario 6.2 - MBH_200_interval====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_interval_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_interval_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:04 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, iedere 8 uur 1 stuk - let op, tijden exact aanhouden, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|iedere 8 uur 1 stuk - let op, tijden exact aanhouden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-2 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-2 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-3 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-3 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-3 />
==== Scenario 6.3 - MBH_200_variabelehoeveelheid====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_variabelehoeveelheid_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag 1 à 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 à 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-3 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-3 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-4 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-4 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-4 />
==== Scenario 6.4 - MBH_200_zonderkeerdosis====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_zonderkeerdosis_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_zonderkeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-4 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-4 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-5 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-5 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-5 />
==== Scenario 6.5 - MBH_200_bijzonderekeerdosis====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_bijzonderekeerdosis_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_bijzonderekeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 0.5 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-5 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-5 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-6 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-6 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-6 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-6 />
==== Scenario 6.6 - MBH_200_variabelehoeveelheid2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_variabelehoeveelheid2_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:18 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72994' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 10 à 15 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-6 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-6 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-7a /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-7a />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-7a /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-7a />
==== Scenario 6.7a - MBH_200_tijdstippen_flexibel====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_tijdstippen_flexibel_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_tijdstippen_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:24 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-7a /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-7a />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-7b /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-7b />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-7b /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-7b />
==== Scenario 6.7b - MBH_200_tijdstippen_niet_flexibel====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_tijdstippen_niet_flexibel_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 10:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, tijden exact aanhouden, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, tijden exact aanhouden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-7b /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-7b />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-8 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-8 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-8 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-8 />
==== Scenario 6.8 - MBH_200_weekdagen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_weekdagen_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_weekdagen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:25 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 70 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 70 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|op maandag, woensdag en vrijdag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-8 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-8 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-9 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-9 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-9 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-9 />
==== Scenario 6.9 - MBH_200_dagdeel====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_dagdeel_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_dagdeel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:27 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, 1 stuk 's avonds, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 stuk 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-9 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-9 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-10 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-10 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-10 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-10 />
==== Scenario 6.10 - MBH_200_cyclischschema====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_cyclischschema_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_cyclischschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:33 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Herhaalperiode cyclisch schema
|style="background-color: white;"|28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-10 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-10 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-11 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-11 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-11 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-11 />
==== Scenario 6.11 - MBH_200_afbouwschema====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_afbouwschema_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_afbouwschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:40 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 41 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 41 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 1
|style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 3
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-11 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-11 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-12 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-12 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-12 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-12 />
==== Scenario 6.12 - MBH_200_variabelehoeveelheidenmaximum====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_variabelehoeveelheidenmaximum_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-12 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-12 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-13 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-13 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-13 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-13 />
==== Scenario 6.13 - MBH_200_toedieningssnelheid====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_toedieningssnelheid_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_toedieningssnelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:47 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 8 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|MORFINEHYDROCHLORIDE 1ML= 5MG EPI CAS 100ML FNA MR (code = '779288' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur, parenteraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-13 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-13 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-14 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-14 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-14 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-14 />
==== Scenario 6.14 - MBH_200_toedieningsduur====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_toedieningsduur_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_toedieningsduur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:49 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk gedurende 16 uur, transdermaal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-14 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-14 />
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-TA-Scenarioset6-v20-6-15 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-15 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset6-v20-6-15 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-15 />
==== Scenario 6.15 - MBH_200_zonodig====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_zonodig_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_zonodig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 09:57 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 27 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_de_Gulle_Gaper|Zorgaanbieder: Apotheek_de_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 27 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_de_Gulle_Gaper" title="Intern ID = Apotheek_de_Gulle_Gaper">Zorgaanbieder Apotheek_de_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek de Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset6-v20-6-15 /><section end=mg-mp-mg-tst-TA-Scenarioset6-v20-6-15 />
== TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)==
<section begin=mg-mp-mg-tst-TA-Scenarioset7-v20-7-1 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset7-v20-7-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset7-v20-7-1 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset7-v20-7-1 />
==== Scenario 7.1 - MBH_200_magistraalalleingredienten====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_200_magistraalalleingredienten_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraalalleingredienten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 13:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 31 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 31 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="11"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 31 dagen, Zo nodig, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|Zo nodig
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset7-v20-7-1 /><section end=mg-mp-mg-tst-TA-Scenarioset7-v20-7-1 />
== TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)==
<section begin=mg-mp-mg-tst-TA-Scenarioset7-v20-7-2 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset7-v20-7-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset7-v20-7-2 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset7-v20-7-2 />
==== Scenario 7.2 - MBH_200_magistraalactieveingredient====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_200_magistraalactieveingredient_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraalactieveingredient_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 13:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 70 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 70 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset7-v20-7-2 /><section end=mg-mp-mg-tst-TA-Scenarioset7-v20-7-2 />
== TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)==
<section begin=mg-mp-mg-tst-TA-Scenarioset7-v20-7-3 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset7-v20-7-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset7-v20-7-3 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset7-v20-7-3 />
==== Scenario 7.3 - MBH_200_magistraal90miljoennr====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_200_magistraal90miljoennr_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraal90miljoennr_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 13:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="8"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product code
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset7-v20-7-3 /><section end=mg-mp-mg-tst-TA-Scenarioset7-v20-7-3 />
== TEST Medicatiegegevens TA Scenarioset 10 (ZI)==
<section begin=mg-mp-mg-tst-TA-Scenarioset10-v20-10-1 /><section begin=patient-mg-mp-mg-tst-TA-Scenarioset10-v20-10-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|J.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Bree
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901588 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jul 2010
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-TA-Scenarioset10-v20-10-1 /><section begin=mbhs-mg-mp-mg-tst-TA-Scenarioset10-v20-10-1 />
==== Scenario 10.1 - MBH_200_ZINRvoorschrijven====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_200_ZINRvoorschrijven_TA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsafspraak datum tijd
|style="background-color: white;"|T om 14:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 150 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-TA-Scenarioset10-v20-10-1 /><section end=mg-mp-mg-tst-TA-Scenarioset10-v20-10-1 />

[[Categorie:Kwalificatie]]

mp:V2.0.0 testgegevens medicatiegegevens raadplegen VV

2022-11-17T10:41:50Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens raadplegend systeem (VV)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''R'''aadplegend systeem (MP-MGR) '''verstrekkingsverzoek'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Stuur voor de genoemde patiënt het 'Medicatiegegevens raadplegen' bericht.
# De simulator verstuurt een 'Medicatiegegevens beschikbaarstellen' bericht met inhoudelijke gegevens.
# Verwerk dit bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier ontvangt als medicatiegegevens raadplegend systeem. Dit zijn de gegevens voor verstrekkingsverzoek.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

==Scenarioset 0: filtercriteria==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-0 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset0-v20-0-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset0-v20-0-1}}
<br>

== Scenarioset 1: verstrekkingsverzoek basale inhoud - extra VV ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-1}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset1-v20-1-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset1-v20-1-1}}

<br>

== Scenarioset 2: verstrekkingsverzoek basale inhoud - andere elementen ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-2}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset2-v20-2-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset2-v20-2-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset2-v20-2-2}}
<br>
<br>
<br>
<br>

== Scenarioset 3 ==
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-3}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset3-v20-3-2 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset3-v20-3-2}}

== Scenarioset 4 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 5 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 6 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 7: verstrekkingsverzoeken met magistraal/eigen artikel ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-7}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset7-v20-7-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset7-v20-7-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset7-v20-7-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset7-v20-7-3}}

== Scenarioset 8: andermans verstrekkingsverzoek ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-8}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset8-v20-8-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset8-v20-8-1}}

== Scenarioset 9: verstrekkingsverzoek - overige elementen ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-9}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1a }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1a}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1b}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1c}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-3}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-4}}
<br>

== Scenarioset 10: verstrekkingsverzoek o.b.v. HPK of ZI-nr ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-10}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset10-v20-10-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset10-v20-10-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset10-v20-10-2}}
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens verstrekkingsverzoek addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens beschikbaarstellen VV

2022-11-17T10:39:12Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens beschikbaarstellend systeem (VV)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''B'''eschikbaarstellend systeem (MP-MGB) '''verstrekkingsverzoek'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Voer de gegevens van alle te testen verstrekkingsverzoeken in voor de persoon genoemd in Persoonsgegevens.
# De simulator verstuurt een 'Medicatiegegevens raadplegen' bericht.
# Ontvang het 'Medicatiegegevens raadplegen' bericht en beantwoord deze met een 'Medicatiegegevens beschikbaarstellen' bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier beschikbaar moet stellen als medicatiegegevens beschikbaarstellend systeem. Dit zijn de gegevens voor verstrekkingsverzoek.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

=== Beschikbaarstellend systeem===
Het beschikbaarstellend systeem voert de gegevens uit de paragrafen "Inhoudelijke gegevens" in het XIS in. Voor een beschikbaarstellend systeem geldt dat sommige gegevens door dit systeem bepaald mogen of moeten worden:

* Zorgverlener, zorgaanbieder (denk aan verstrekker, voorschrijver). Dit mag een eigen (test)zorgverlener en organisatie zijn.
* Identificatie van medicamenteuze behandeling, medicatiebouwstenen (verstrekkingsverzoek). LET OP: verwacht wordt dat hier 'eigen' identificaties aan worden toegekend in een eigen identificatiesysteem (eigen OID). De onderlinge referenties moeten natuurlijk wel kloppen (dus een toedieningsafspraak en een medicatieverstrekking blijven horen bij dezelfde medicamenteuze behandeling als de medicatieafspraak en verstrekkingsverzoek vanuit de voorschrijver). De identificatie van medicamenteuze behandeling mag niet door het beschikbaarstellend systeem bepaald worden indien het aanpassingen betreft op andermans medicamenteuze behandeling.
* Product code voor een 90 miljoennummer. LET OP: verwacht wordt dat hier de root oid van de organisatie in combinatie met het 90 miljoennummer worden toegekend.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

==Scenarioset 0: filtercriteria==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-0 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset0-v20-0-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset0-v20-0-1}}
<br>

== Scenarioset 1: verstrekkingsverzoek basale inhoud - extra VV ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-1}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset1-v20-1-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset1-v20-1-1}}

<br>

== Scenarioset 2: verstrekkingsverzoek basale inhoud - andere elementen ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-2}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset2-v20-2-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset2-v20-2-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset2-v20-2-2}}
<br>
<br>
<br>
<br>

== Scenarioset 3 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 4 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 5 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 6 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 7: verstrekkingsverzoeken met magistraal/eigen artikel ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-7}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset7-v20-7-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset7-v20-7-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset7-v20-7-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset7-v20-7-3}}

== Scenarioset 8: andermans verstrekkingsverzoek ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-8}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset8-v20-8-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset8-v20-8-1}}

== Scenarioset 9: verstrekkingsverzoek - overige elementen ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-9}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1a }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1a}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1b}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1c}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-2}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-3}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-4}}
<br>

== Scenarioset 10: verstrekkingsverzoek o.b.v. HPK of ZI-nr ==
=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|overview-MGR-10}}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|patient-mg-mp-mg-tst-VV-Scenarioset10-v20-10-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset10-v20-10-1}}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|mbhs-mg-mp-mg-tst-VV-Scenarioset10-v20-10-2}}
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_VV_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens verstrekkingsverzoek addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens VV addendum

2022-11-17T10:38:06Z

Tim Schuller:

__NUMBEREDHEADINGS__
{{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens 9 2.0 - VV: addendum inhoudelijke gegevens kwalificatie}}

=Addenda voor inhoudelijke gegevens=
== Overzicht van scenario's voor sturend/beschikbaarstellend systeem ==

=== Scenarioset 0===
<section begin=overview-MGB-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| || Alle verstrekkingsverzoeken van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 6 verstrekkingsverzoeken)
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| || Specifieke verstrekkingsverzoek met identificaties als filter (in kwalificatiesimulator het id van "MBH_200_QA1_VV" invoeren)<br/>(Antwoord: bericht met 1 verstrekkingsverzoek)
|-style="vertical-align:top;|style="background-color: white;"
|0.3 optioneel|| || Verstrekkingsverzoek met een filter op productcode (PRK 3956)<br/>(Antwoord: bericht met 1 verstrekkingsverzoek)
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| || Verstrekkingsverzoeken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_200_QA1" invoeren)<br/>(Antwoord: bericht met 1 verstrekkingsverzoek)
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| || Een antwoord zonder verstrekkingsverzoeken (filter op een niet in het systeem aanwezige id "MBH_200_QAnietaanwezig")<br/>(Antwoord: bericht zonder verstrekkingsverzoek)
|}
<section end=overview-MGB-0 />
=== Scenarioset 1===
<section begin=overview-MGB-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| VV id
|-style="vertical-align:top;|style="background-color: white;"
|1.1|| Maak screenshot(s) waaruit blijkt dat er meerdere VVs gemaakt en opgeleverd kunnen worden/behoren bij één MA.|| Initieel verstrekkingsverzoek en extra verstrekkingsverzoek behorende bij één MA|| MBH_200_chronisch|| MBH_200_chronisch_VV<br/>MBH_200_chronisch_VV_extraVVbestaandeMA
|}
<section end=overview-MGB-1 />
=== Scenarioset 2===
<section begin=overview-MGB-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| VV id
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_200_toelichting|| MBH_200_toelichting_VV
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende wensen' zichtbaar zijn|| Aanvullende wensen|| MBH_200_aanvullendeinformatiewensen|| MBH_200_aanvullendeinformatiewensen_VV
|}
<section end=overview-MGB-2 />
=== Scenarioset 7===
<section begin=overview-MGB-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| VV id
|-style="vertical-align:top;|style="background-color: white;"
|7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_200_magistraalalleingredienten|| MBH_200_magistraalalleingredienten_VV
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_200_magistraalactieveingredient|| MBH_200_magistraalactieveingredient_VV
|-style="vertical-align:top;|style="background-color: white;"
|7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_200_magistraal90miljoennr|| MBH_200_magistraal90miljoennr_VV
|}
<section end=overview-MGB-7 />
=== Scenarioset 9===
<section begin=overview-MGB-9 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| VV id
|-style="vertical-align:top;|style="background-color: white;"
|9.1a || Maak screenshot(s) waarin zichtbaar is dat een logistieke verbruiksperiode ingevoerd kan worden (ingangsdatum en duur/einddatum)|| Logistieke verbruiksperiode|| MBH_200_logistiekeverbruiksperiode_start_eind|| MBH_200_logistiekeverbruiksperiode_start_eind_VV
|-style="vertical-align:top;|style="background-color: white;"
|9.1b|| || Logistieke verbruiksperiode|| MBH_200_logistiekeverbruiksperiode_eind|| MBH_200_logistiekeverbruiksperiode_eind_VV
|-style="vertical-align:top;|style="background-color: white;"
|9.1c|| || Logistieke verbruiksperiode|| MBH_200_logistiekeverbruiksperiode_duur_dagen|| MBH_200_logistiekeverbruiksperiode_duur_dagen_VV
|-style="vertical-align:top;|style="background-color: white;"
|9.2|| Maak screenshot(s) waarin zichtbaar is dat het aantal herhalingen ingevuld kan worden|| Herhalingen|| MBH_200_herhalingen|| MBH_200_herhalingen_VV
|-style="vertical-align:top;|style="background-color: white;"
|9.3|| Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden|| Afleverlocatie|| MBH_200_afleverlocatie|| MBH_200_afleverlocatie_VV
|-style="vertical-align:top;|style="background-color: white;"
|9.4|| || Financiele indicatiecode|| MBH_200_financiele_indicatiecode|| MBH_200_financiele_indicatiecode_VV
|}
<section end=overview-MGB-9 />
=== Scenarioset 10===
<section begin=overview-MGB-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| VV id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| || HPK geneesmiddel|| MBH_200_HPKvoorschrijven|| MBH_200_HPKvoorschrijven_VV
|-style="vertical-align:top;|style="background-color: white;"
|10.2|| || ZI-nr geneesmiddel|| MBH_200_ZINRvoorschrijven|| MBH_200_ZINRvoorschrijven_VV
|}
<section end=overview-MGB-10 />
== Overzicht van scenario's voor ontvangend/raadplegend systeem ==

=== Scenarioset 0===
<section begin=overview-MGR-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| Alle verstrekkingsverzoeken van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 6 verstrekkingsverzoeken)
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| Specifieke verstrekkingsverzoek met identificaties als filter (in kwalificatiesimulator het id van "MBH_200_QA1_VV" invoeren)<br/>(Antwoord: bericht met 1 verstrekkingsverzoek)
|-style="vertical-align:top;|style="background-color: white;"
|0.3|| Verstrekkingsverzoek met een filter op productcode (PRK 3956)<br/>(Antwoord: bericht met 1 verstrekkingsverzoek)
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| Verstrekkingsverzoeken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_200_QA1" invoeren)<br/>(Antwoord: bericht met 1 verstrekkingsverzoek)
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| Een antwoord zonder verstrekkingsverzoeken (filter op een niet in het systeem aanwezige id "MBH_200_QAnietaanwezig")<br/>(Antwoord: bericht zonder verstrekkingsverzoek)
|}
<section end=overview-MGR-0 />
=== Scenarioset 1===
<section begin=overview-MGR-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| VV id
|-style="vertical-align:top;|style="background-color: white;"
|1.1|| Initieel verstrekkingsverzoek en extra verstrekkingsverzoek behorende bij één MA|| MBH_200_chronisch|| MBH_200_chronisch_VV<br/>MBH_200_chronisch_VV_extraVVbestaandeMA
|}
<section end=overview-MGR-1 />
=== Scenarioset 2===
<section begin=overview-MGR-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| VV id
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| Toelichting|| MBH_200_toelichting|| MBH_200_toelichting_VV
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Aanvullende wensen|| MBH_200_aanvullendeinformatiewensen|| MBH_200_aanvullendeinformatiewensen_VV
|}
<section end=overview-MGR-2 />
=== Scenarioset 7===
<section begin=overview-MGR-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| VV id
|-style="vertical-align:top;|style="background-color: white;"
|7.1|| Alle ingrediënten|| MBH_200_magistraalalleingredienten|| MBH_200_magistraalalleingredienten_VV
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| Actief ingrediënt|| MBH_200_magistraalactieveingredient|| MBH_200_magistraalactieveingredient_VV
|-style="vertical-align:top;|style="background-color: white;"
|7.3|| 90 miljoen nummer|| MBH_200_magistraal90miljoennr|| MBH_200_magistraal90miljoennr_VV
|}
<section end=overview-MGR-7 />
=== Scenarioset 9===
<section begin=overview-MGR-9 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| VV id
|-style="vertical-align:top;|style="background-color: white;"
|9.1a|| Logistieke verbruiksperiode|| MBH_200_logistiekeverbruiksperiode_start_eind|| MBH_200_logistiekeverbruiksperiode_start_eind_VV
|-style="vertical-align:top;|style="background-color: white;"
|9.1b|| Logistieke verbruiksperiode|| MBH_200_logistiekeverbruiksperiode_eind|| MBH_200_logistiekeverbruiksperiode_eind_VV
|-style="vertical-align:top;|style="background-color: white;"
|9.1c|| Logistieke verbruiksperiode|| MBH_200_logistiekeverbruiksperiode_duur_dagen|| MBH_200_logistiekeverbruiksperiode_duur_dagen_VV
|-style="vertical-align:top;|style="background-color: white;"
|9.2|| Herhalingen|| MBH_200_herhalingen|| MBH_200_herhalingen_VV
|-style="vertical-align:top;|style="background-color: white;"
|9.3|| Afleverlocatie|| MBH_200_afleverlocatie|| MBH_200_afleverlocatie_VV
|-style="vertical-align:top;|style="background-color: white;"
|9.4|| Financiele indicatiecode|| MBH_200_financiele_indicatiecode|| MBH_200_financiele_indicatiecode_VV
|}
<section end=overview-MGR-9 />
=== Scenarioset 10===
<section begin=overview-MGR-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| VV id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| HPK geneesmiddel|| MBH_200_HPKvoorschrijven|| MBH_200_HPKvoorschrijven_VV
|-style="vertical-align:top;|style="background-color: white;"
|10.2|| ZI-nr geneesmiddel|| MBH_200_ZINRvoorschrijven|| MBH_200_ZINRvoorschrijven_VV
|}
<section end=overview-MGR-10 />
== TEST Medicatiegegevens VV Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-VV-Scenarioset0-v20-0-1 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset0-v20-0-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset0-v20-0-1 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset0-v20-0-1 />
==== Scenario 0.1 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_QA1_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|60 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_QA1_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_QA2_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA2_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 100 dagen om 08:04 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|300 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_QA2_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_QA3_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 50 dagen om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|4000 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_QA3_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_QA4_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 10 dagen om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_QA4_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA5====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_QA5_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA5_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 50 dagen om 08:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|56 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_QA5_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA6====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_QA6_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA6_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 5 dagen om 08:18 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|21 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_QA6_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset0-v20-0-1 /><section end=mg-mp-mg-tst-VV-Scenarioset0-v20-0-1 />
== TEST Medicatiegegevens VV Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-VV-Scenarioset0-v20-0-2 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset0-v20-0-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset0-v20-0-2 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset0-v20-0-2 />
==== Scenario 0.2 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_QA1_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|60 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_QA1_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset0-v20-0-2 /><section end=mg-mp-mg-tst-VV-Scenarioset0-v20-0-2 />
== TEST Medicatiegegevens VV Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-VV-Scenarioset0-v20-0-3optioneel /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset0-v20-0-3optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset0-v20-0-3optioneel /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset0-v20-0-3optioneel />
==== Scenario 0.3 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_QA4_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 10 dagen om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_QA4_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset0-v20-0-3optioneel /><section end=mg-mp-mg-tst-VV-Scenarioset0-v20-0-3optioneel />
== TEST Medicatiegegevens VV Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-VV-Scenarioset0-v20-0-4 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset0-v20-0-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset0-v20-0-4 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset0-v20-0-4 />
==== Scenario 0.4 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_QA1_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|60 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_QA1_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset0-v20-0-4 /><section end=mg-mp-mg-tst-VV-Scenarioset0-v20-0-4 />
== TEST Medicatiegegevens VV Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-VV-Scenarioset0-v20-0-5 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset0-v20-0-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset0-v20-0-5 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset0-v20-0-5 /><section end=mbhs-mg-mp-mg-tst-VV-Scenarioset0-v20-0-5 /><section end=mg-mp-mg-tst-VV-Scenarioset0-v20-0-5 />
== TEST Medicatiegegevens VV Scenarioset 1==
<section begin=mg-mp-mg-tst-VV-Scenarioset1-v20-1-1 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset1-v20-1-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset1-v20-1-1 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset1-v20-1-1 />
==== Scenario 1.1 - MBH_200_chronisch====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_chronisch_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_chronisch_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 30 dagen om 11:32 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|21 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_chronisch_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_chronisch_VV_extraVVbestaandeMA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_chronisch_VV_extraVVbestaandeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 10 dagen om 11:35 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|90 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_chronisch_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset1-v20-1-1 /><section end=mg-mp-mg-tst-VV-Scenarioset1-v20-1-1 />
== TEST Medicatiegegevens VV Scenarioset 2==
<section begin=mg-mp-mg-tst-VV-Scenarioset2-v20-2-1 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset2-v20-2-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset2-v20-2-1 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset2-v20-2-1 />
==== Scenario 2.1 - MBH_200_toelichting====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_toelichting_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_toelichting_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 21 dagen om 08:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toelichting
|style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_toelichting_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset2-v20-2-1 /><section end=mg-mp-mg-tst-VV-Scenarioset2-v20-2-1 />
== TEST Medicatiegegevens VV Scenarioset 2==
<section begin=mg-mp-mg-tst-VV-Scenarioset2-v20-2-2 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset2-v20-2-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset2-v20-2-2 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset2-v20-2-2 />
==== Scenario 2.2 - MBH_200_aanvullendeinformatiewensen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_aanvullendeinformatiewensen_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 5 dagen om 08:06 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aanvullende wensen
|style="background-color: white;"|Bezorgen (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2051')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset2-v20-2-2 /><section end=mg-mp-mg-tst-VV-Scenarioset2-v20-2-2 />
== TEST Medicatiegegevens VV Scenarioset 7 (Magistraal)==
<section begin=mg-mp-mg-tst-VV-Scenarioset7-v20-7-1 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset7-v20-7-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset7-v20-7-1 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset7-v20-7-1 />
==== Scenario 7.1 - MBH_200_magistraalalleingredienten====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_200_magistraalalleingredienten_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraalalleingredienten_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T om 12:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|style="background-color: white;"|100 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="11"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_magistraalalleingredienten_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset7-v20-7-1 /><section end=mg-mp-mg-tst-VV-Scenarioset7-v20-7-1 />
== TEST Medicatiegegevens VV Scenarioset 7 (Magistraal)==
<section begin=mg-mp-mg-tst-VV-Scenarioset7-v20-7-2 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset7-v20-7-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset7-v20-7-2 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset7-v20-7-2 />
==== Scenario 7.2 - MBH_200_magistraalactieveingredient====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_200_magistraalactieveingredient_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraalactieveingredient_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T om 12:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|style="background-color: white;"|100 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_magistraalactieveingredient_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset7-v20-7-2 /><section end=mg-mp-mg-tst-VV-Scenarioset7-v20-7-2 />
== TEST Medicatiegegevens VV Scenarioset 7 (Magistraal)==
<section begin=mg-mp-mg-tst-VV-Scenarioset7-v20-7-3 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset7-v20-7-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset7-v20-7-3 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset7-v20-7-3 />
==== Scenario 7.3 - MBH_200_magistraal90miljoennr====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek MBH_200_magistraal90miljoennr_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraal90miljoennr_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T om 12:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Te verstrekken hoeveelheid
|style="background-color: white;"|100 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="8"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product code
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_magistraal90miljoennr_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset7-v20-7-3 /><section end=mg-mp-mg-tst-VV-Scenarioset7-v20-7-3 />
== TEST Medicatiegegevens VV Scenarioset 9 (diversen VV)==
<section begin=mg-mp-mg-tst-VV-Scenarioset9-v20-9-1a /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1a />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Tewarie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900961 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|9 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1a /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1a />
==== Scenario 9.1a - MBH_200_logistiekeverbruiksperiode_start_eind====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_logistiekeverbruiksperiode_start_eind_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T om 11:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verbruiksperiode
|style="background-color: white;"|Vanaf T, tot en met T + 12 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_start_eind_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1a /><section end=mg-mp-mg-tst-VV-Scenarioset9-v20-9-1a />
== TEST Medicatiegegevens VV Scenarioset 9 (diversen VV)==
<section begin=mg-mp-mg-tst-VV-Scenarioset9-v20-9-1b /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1b />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Tewarie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900961 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|9 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1b /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1b />
==== Scenario 9.1b - MBH_200_logistiekeverbruiksperiode_eind====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_logistiekeverbruiksperiode_eind_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 9 dagen om 11:01 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verbruiksperiode
|style="background-color: white;"|tot en met T + 200 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_eind_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1b /><section end=mg-mp-mg-tst-VV-Scenarioset9-v20-9-1b />
== TEST Medicatiegegevens VV Scenarioset 9 (diversen VV)==
<section begin=mg-mp-mg-tst-VV-Scenarioset9-v20-9-1c /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1c />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Tewarie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900961 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|9 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1c /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1c />
==== Scenario 9.1c - MBH_200_logistiekeverbruiksperiode_duur_dagen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_logistiekeverbruiksperiode_duur_dagen_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_duur_dagen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T om 11:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verbruiksperiode
|style="background-color: white;"|gedurende 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_duur_dagen_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_logistiekeverbruiksperiode_duur_dagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-1c /><section end=mg-mp-mg-tst-VV-Scenarioset9-v20-9-1c />
== TEST Medicatiegegevens VV Scenarioset 9 (diversen VV)==
<section begin=mg-mp-mg-tst-VV-Scenarioset9-v20-9-2 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Tewarie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900961 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|9 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-2 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-2 />
==== Scenario 9.2 - MBH_200_herhalingen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_herhalingen_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_herhalingen_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 50 dagen om 11:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aantal herhalingen
|style="background-color: white;"|5
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_herhalingen_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-2 /><section end=mg-mp-mg-tst-VV-Scenarioset9-v20-9-2 />
== TEST Medicatiegegevens VV Scenarioset 9 (diversen VV)==
<section begin=mg-mp-mg-tst-VV-Scenarioset9-v20-9-3 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Tewarie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900961 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|9 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-3 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-3 />
==== Scenario 9.3 - MBH_200_afleverlocatie====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_afleverlocatie_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_afleverlocatie_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T om 11:07 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|30 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Afleverlocatie
|style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_afleverlocatie_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-3 /><section end=mg-mp-mg-tst-VV-Scenarioset9-v20-9-3 />
== TEST Medicatiegegevens VV Scenarioset 9 (diversen VV)==
<section begin=mg-mp-mg-tst-VV-Scenarioset9-v20-9-4 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Tewarie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900961 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|9 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset9-v20-9-4 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-4 />
==== Scenario 9.4 - MBH_200_financiele_indicatiecode====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_financiele_indicatiecode_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_financiele_indicatiecode_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T om 11:35 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|56 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM 10MG TABLET (code = '353' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Financiele indicatiecode
|style="background-color: white;"|(code = 'OTH' in codeSystem 'NullFlavor'): B2
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_financiele_indicatiecode_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_financiele_indicatiecode (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset9-v20-9-4 /><section end=mg-mp-mg-tst-VV-Scenarioset9-v20-9-4 />
== TEST Medicatiegegevens VV Scenarioset 10 (HPKZI)==
<section begin=mg-mp-mg-tst-VV-Scenarioset10-v20-10-1 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset10-v20-10-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|J.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Bree
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901588 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jul 2010
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset10-v20-10-1 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset10-v20-10-1 />
==== Scenario 10.1 - MBH_200_HPKvoorschrijven====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_HPKvoorschrijven_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_HPKvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T - 170 dagen om 13:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|150 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_HPKvoorschrijven_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset10-v20-10-1 /><section end=mg-mp-mg-tst-VV-Scenarioset10-v20-10-1 />
== TEST Medicatiegegevens VV Scenarioset 10 (HPKZI)==
<section begin=mg-mp-mg-tst-VV-Scenarioset10-v20-10-2 /><section begin=patient-mg-mp-mg-tst-VV-Scenarioset10-v20-10-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|J.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Bree
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901588 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jul 2010
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-VV-Scenarioset10-v20-10-2 /><section begin=mbhs-mg-mp-mg-tst-VV-Scenarioset10-v20-10-2 />
==== Scenario 10.2 - MBH_200_ZINRvoorschrijven====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Verstrekkingsverzoek MBH_200_ZINRvoorschrijven_VV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Verstrekkingsverzoek datum tijd
|style="background-color: white;"|T om 13:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Auteur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Te verstrekken hoeveelheid
|style="background-color: white;"|150 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Beoogd verstrekker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Apotheek_De_Gulle_Gaper|Zorgaanbieder: Apotheek_De_Gulle_Gaper]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Relatie medicatieafspraak
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_MA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Apotheek_De_Gulle_Gaper" title="Intern ID = Apotheek_De_Gulle_Gaper">Zorgaanbieder Apotheek_De_Gulle_Gaper</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|01236578 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Apotheek De Gulle Gaper
|}<section end=mbhs-mg-mp-mg-tst-VV-Scenarioset10-v20-10-2 /><section end=mg-mp-mg-tst-VV-Scenarioset10-v20-10-2 />

[[Categorie:Kwalificatie]]

mp:V2.0.0 testgegevens medicatiegegevens raadplegen MA

2022-11-17T10:35:05Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens raadplegend systeem (MA)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''R'''aadplegend systeem (MP-MGR) '''medicatieafspraak'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Stuur voor de genoemde patiënt het 'Medicatiegegevens raadplegen' bericht.
# De simulator verstuurt een 'Medicatiegegevens beschikbaarstellen' bericht met inhoudelijke gegevens.
# Verwerk dit bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier ontvangt als medicatiegegevens raadplegend systeem. Dit zijn de gegevens voor medicatieafspraak.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

==Scenarioset 0: filtercriteria==

=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-0 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-1 }}
<br>
<br>
<br>

== Scenarioset 1: medicatieafspraak basale inhoud - gebruiksperiode ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-1 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2a }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2b }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-4 }}
<br>
<br>
<br>

== Scenarioset 2: medicatieafspraak basale inhoud - andere elementen ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-2 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-4 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-5 }}
<br>
<br>
<br>

== Scenarioset 3: stop-medicatieafspraken (staken, wijzigen, onderbreken) ==
=== Doel en verwacht resultaat ===

{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Doel|| Verwacht resultaat
|-style="vertical-align:top;|style="background-color: white;"
|Aantonen dat het systeem correct omgaat met het beschikbaarstellen van stop-medicatieafspraken (staken) || Het systeem levert correcte stop-medicatieafspraak (staken) op
|-style="vertical-align:top; style="background-color: white;"
|Aantonen dat het systeem correct omgaat met het beschikbaarstellen van technische stop-medicatieafspraken als onderdeel van een wijziging
||Het systeem levert een inhoudelijk correcte technische stop-medicatieafspraak op in het geval van een wijziging. De technische stop-medicatieafspraak wordt niet als zodanig getoond aan de eindgebruiker.
|-style="vertical-align:top; style="background-color: white;"
|Aantonen dat het systeem correct omgaat met de reden wijzigen of staken ||Het systeem gaat correct om met de reden wijzigen of staken. De reden van wijzigen wordt opgeleverd in de nieuwe medicatieafspraak.
|-style="vertical-align:top; style="background-color: white;"
|Aantonen dat het systeem correct omgaat met het beschikbaarstellen van tijdelijk onderbroken medicatieafspraken||Het systeem levert een stop-medicatieafspraak (onderbreken) op
|}

=== Scenario’s ===

<font color=#FF0000>LET OP: onderstaande scenario's bevatten medicatieafspraken welke gestopt (tijdelijk/definitief) of gewijzigd zijn.</font>
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-3 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-4 }}
<br>
<br>
<br>

== Scenarioset 4 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 5 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 6: medicatieafspraken met diverse doseerschema's ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-6 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-4 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-5 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-6 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7a }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7b }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-8 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-9 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-10 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-11 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-12 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-13 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-14 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-15 }}
<br>
<br>
<br>

== Scenarioset 7: medicatieafspraken met magistraal/eigen artikel ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-7 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset7-v20-7-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-3 }}
<br>
<br>
<br>

== Scenarioset 8: andermans medicatieafspraak ==
{{NoteBox|Scenarioset 8 is van toepassing voor ''Medicatiegegevens beschikbaarstellend systeem (MP-MGB) - MA'' indien leverancier al gekwalificeerd is voor ''Medicatiegegevens raadplegend systeem (MP-MGR) - MA''}}
=== Doel en verwacht resultaat ===

{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Doel|| Verwacht resultaat
|-style="vertical-align:top;|style="background-color: white;"
|Aantonen dat er geen medicatieafspraken van een ander opgeleverd worden ||Het systeem levert geen medicatieafspraken op met kopie indicator.
|}

=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-8 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset8-v20-8-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset8-v20-8-1 }}
<br>
<br>
<br>

== Scenarioset 9 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 10: medicatieafspraak o.b.v. HPK of ZI-nr ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-10 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset10-v20-10-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset10-v20-10-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset10-v20-10-2 }}
<br>
<br>
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-05-23
|style="background-color: white;"| Code bij "Reden van voorschrijven" scenario 2.3 correctie [https://bits.nictiz.nl/browse/MP-593 BITS MP-593]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens medicatieafspraak addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens beschikbaarstellen MA

2022-11-17T10:01:57Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens beschikbaarstellend systeem (MA)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''B'''eschikbaarstellend systeem (MP-MGB) '''medicatieafspraak'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Voer de gegevens van alle te testen medicatieafspraken in voor de persoon genoemd in Persoonsgegevens.
# De simulator verstuurt een 'Medicatiegegevens raadplegen' bericht.
# Ontvang het 'Medicatiegegevens raadplegen' bericht en beantwoord deze met een 'Medicatiegegevens beschikbaarstellen' bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier beschikbaar moet stellen als medicatiegegevens beschikbaarstellend systeem. Dit zijn de gegevens voor medicatieafspraak.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

=== Beschikbaarstellend systeem===
Het beschikbaarstellend systeem voert de gegevens uit de paragrafen "Inhoudelijke gegevens" in het XIS in. Voor een beschikbaarstellend systeem geldt dat sommige gegevens door dit systeem bepaald mogen of moeten worden:

* Zorgverlener, zorgaanbieder (denk aan verstrekker, voorschrijver). Dit mag een eigen (test)zorgverlener en organisatie zijn.
* Identificatie van medicamenteuze behandeling, medicatiebouwstenen (medicatieafspraak). LET OP: verwacht wordt dat hier 'eigen' identificaties aan worden toegekend in een eigen identificatiesysteem (eigen OID). De onderlinge referenties moeten natuurlijk wel kloppen (dus een toedieningsafspraak en een medicatieverstrekking blijven horen bij dezelfde medicamenteuze behandeling als de medicatieafspraak en verstrekkingsverzoek vanuit de voorschrijver). De identificatie van medicamenteuze behandeling mag niet door het beschikbaarstellend systeem bepaald worden indien het aanpassingen betreft op andermans medicamenteuze behandeling.
* Product code voor een 90 miljoennummer. LET OP: verwacht wordt dat hier de root oid van de organisatie in combinatie met het 90 miljoennummer worden toegekend.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

==Scenarioset 0: filtercriteria==

=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-0 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-1 }}
<br>
<br>
<br>

== Scenarioset 1: medicatieafspraak basale inhoud - gebruiksperiode ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-1 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2a }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2b }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-4 }}
<br>
<br>
<br>

== Scenarioset 2: medicatieafspraak basale inhoud - andere elementen ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-2 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-4 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-5 }}
<br>
<br>
<br>

== Scenarioset 3: stop-medicatieafspraken (staken, wijzigen, onderbreken) ==
=== Doel en verwacht resultaat ===

{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Doel|| Verwacht resultaat
|-style="vertical-align:top;|style="background-color: white;"
|Aantonen dat het systeem correct omgaat met het beschikbaarstellen van stop-medicatieafspraken (staken) || Het systeem levert correcte stop-medicatieafspraak (staken) op
|-style="vertical-align:top; style="background-color: white;"
|Aantonen dat het systeem correct omgaat met het beschikbaarstellen van technische stop-medicatieafspraken als onderdeel van een wijziging
||Het systeem levert een inhoudelijk correcte technische stop-medicatieafspraak op in het geval van een wijziging. De technische stop-medicatieafspraak wordt niet als zodanig getoond aan de eindgebruiker.
|-style="vertical-align:top; style="background-color: white;"
|Aantonen dat het systeem correct omgaat met de reden wijzigen of staken ||Het systeem gaat correct om met de reden wijzigen of staken. De reden van wijzigen wordt opgeleverd in de nieuwe medicatieafspraak.
|-style="vertical-align:top; style="background-color: white;"
|Aantonen dat het systeem correct omgaat met het beschikbaarstellen van tijdelijk onderbroken medicatieafspraken||Het systeem levert een stop-medicatieafspraak (onderbreken) op
|}

=== Scenario’s ===

<font color=#FF0000>LET OP: onderstaande scenario's bevatten medicatieafspraken welke gestopt (tijdelijk/definitief) of gewijzigd zijn.</font>
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-3 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-4 }}
<br>
<br>
<br>

== Scenarioset 4 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 5 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 6: medicatieafspraken met diverse doseerschema's ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-6 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-4 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-5 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-6 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7a }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7b }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-8 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-9 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-10 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-11 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-12 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-13 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-14 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-15 }}
<br>
<br>
<br>

== Scenarioset 7: medicatieafspraken met magistraal/eigen artikel ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-7 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset7-v20-7-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-3 }}
<br>
<br>
<br>

== Scenarioset 8: andermans medicatieafspraak ==
{{NoteBox|Scenarioset 8 is van toepassing voor ''Medicatiegegevens beschikbaarstellend systeem (MP-MGB) - MA'' indien leverancier al gekwalificeerd is voor ''Medicatiegegevens raadplegend systeem (MP-MGR) - MA''}}
=== Doel en verwacht resultaat ===

{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Doel|| Verwacht resultaat
|-style="vertical-align:top;|style="background-color: white;"
|Aantonen dat er geen medicatieafspraken van een ander opgeleverd worden ||Het systeem levert geen medicatieafspraken op met kopie indicator.
|}

=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-8 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset8-v20-8-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset8-v20-8-1 }}
<br>
<br>
<br>

== Scenarioset 9 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 10: medicatieafspraak o.b.v. HPK of ZI-nr ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-10 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset10-v20-10-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset10-v20-10-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset10-v20-10-2 }}
<br>
<br>
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-05-23
|style="background-color: white;"| Code bij "Reden van voorschrijven" scenario 2.3 correctie [https://bits.nictiz.nl/browse/MP-593 BITS MP-593]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Scenarioset 8 verwijderd uit test script [https://bits.nictiz.nl/browse/MP-738 BITS MP-738]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens medicatieafspraak addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens beschikbaarstellen MA

2022-11-17T09:55:47Z

Tim Schuller: /* Documenthistorie */

{{DISPLAYTITLE:Medicatieproces 9 versie 2.0.0 - testgegevens - medicatiegegevens beschikbaarstellend systeem (MA)}}

__NUMBEREDHEADINGS__
[[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]]

[[mp:Vcurrent_Kwalificatie#Medicatieproces_9_versie_2.0.0_testmateriaal_en_kwalificatiescripts_voor_Kickstart|Terug naar alle testscenario's]]

== Inleiding ==
Dit document biedt de mogelijkheid voor het testen van de systeemrol:
* '''''M'''edicatie'''G'''egevens '''B'''eschikbaarstellend systeem (MP-MGB) '''medicatieafspraak'''''.

De doelgroep van dit document is de leverancier die '''zelfstandig testen uitvoert ter voorbereiding op de kwalificatie'''
<br> Het testen geeft de mogelijkheid om de technische berichten te controleren. Visuele controle van screenshots is geen onderdeel van het testen.<br>
<br>
De testmaterialen kunnen worden aangevuld en gewijzigd (n.a.v. bevindingen). <br>
Deze aanpassingen worden vermeld in de documenthistorie.<br>

Feedback en bevindingen op het testmateriaal? : validatie@medicatieoverdracht.nl

== Uit te voeren stappen ==

Voer – voor ieder 'Scenarioset' hoofdstuk – de volgende stappen uit:
# Voer de gegevens van alle te testen medicatieafspraken in voor de persoon genoemd in Persoonsgegevens.
# De simulator verstuurt een 'Medicatiegegevens raadplegen' bericht.
# Ontvang het 'Medicatiegegevens raadplegen' bericht en beantwoord deze met een 'Medicatiegegevens beschikbaarstellen' bericht.

== Leeswijzer ==
Ieder navolgend hoofdstuk beschrijft een set scenario’s met steeds dezelfde paragraafindeling:
# Scenario’s
# Inhoudelijke gegevens

===Scenario's===
In deze paragraaf zijn alle scenario's van het betreffende hoofdstuk beschreven. <br>

De kolom 'beschrijving' geeft aan wat de testcase is en kan tevens aanvullende informatie en instructies bevatten.<br>
Bij elk scenario staan de id's van de Medicamenteuze Behandeling en de bouwstenen vermeld zoals die ook terug te vinden zijn in de paragraaf "Inhoudelijke gegevens" van het betreffende hoofdstuk.

=== Inhoudelijke gegevens ===
Dit onderdeel bevat de ‘Persoonsgegevens’ zoals naam, adres en woonplaats, maar ook een (fictief) Burgerservicenummer (BSN). Daarnaast bevat deze paragraaf de specifieke gegevens die de leverancier beschikbaar moet stellen als medicatiegegevens beschikbaarstellend systeem. Dit zijn de gegevens voor medicatieafspraak.

=== Gebruikersschermen===
Hoe de gebruikersschermen van een systeem er precies uitzien, is vrij in te vullen (immers: juist gebruikersvriendelijkheid is iets waarop leveranciers moeten kunnen concurreren), mits alle informatie in de juiste samenhang met de juiste semantiek (betekenis) is terug te vinden. Dit betekent dat bouwstenen behorende bij dezelfde medicamenteuze behandeling als zodanig herkenbaar moeten zijn. Een applicatie hoeft niet de (technische) identificatie van een MBH te tonen (noch die van andere bouwstenen), maar wel de uitwerking daarvan: namelijk in samenhang getoonde bouwstenen en bouwsteen instantiaties.
Samenhang en correcte verwerking is onder andere belangrijk voor de medicamenteuze behandeling (MBH), wijzigingen en stops.

=== Beschikbaarstellend systeem===
Het beschikbaarstellend systeem voert de gegevens uit de paragrafen "Inhoudelijke gegevens" in het XIS in. Voor een beschikbaarstellend systeem geldt dat sommige gegevens door dit systeem bepaald mogen of moeten worden:

* Zorgverlener, zorgaanbieder (denk aan verstrekker, voorschrijver). Dit mag een eigen (test)zorgverlener en organisatie zijn.
* Identificatie van medicamenteuze behandeling, medicatiebouwstenen (medicatieafspraak). LET OP: verwacht wordt dat hier 'eigen' identificaties aan worden toegekend in een eigen identificatiesysteem (eigen OID). De onderlinge referenties moeten natuurlijk wel kloppen (dus een toedieningsafspraak en een medicatieverstrekking blijven horen bij dezelfde medicamenteuze behandeling als de medicatieafspraak en verstrekkingsverzoek vanuit de voorschrijver). De identificatie van medicamenteuze behandeling mag niet door het beschikbaarstellend systeem bepaald worden indien het aanpassingen betreft op andermans medicamenteuze behandeling.
* Product code voor een 90 miljoennummer. LET OP: verwacht wordt dat hier de root oid van de organisatie in combinatie met het 90 miljoennummer worden toegekend.

===Datum T===
T is de datum die voor het testen wordt gebruikt. Als ergens staat T – 100D betekent dit: 100 dagen eerder dan die afgesproken datum.<br>
Gebruiksperiode ingangsdatum en einddatum: in het testmateriaal wordt uitgegaan van de gehele dag T. Dit komt neer op ingangsdatum {00:00:00} '''tot en met''' einddatum {23:59:59}.

==Scenarioset 0: filtercriteria==

=== Scenario’s ===

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-0 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-1 }}
<br>
<br>
<br>

== Scenarioset 1: medicatieafspraak basale inhoud - gebruiksperiode ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-1 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2a }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2b }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-4 }}
<br>
<br>
<br>

== Scenarioset 2: medicatieafspraak basale inhoud - andere elementen ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-2 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-4 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-5 }}
<br>
<br>
<br>

== Scenarioset 3: stop-medicatieafspraken (staken, wijzigen, onderbreken) ==
=== Doel en verwacht resultaat ===

{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Doel|| Verwacht resultaat
|-style="vertical-align:top;|style="background-color: white;"
|Aantonen dat het systeem correct omgaat met het beschikbaarstellen van stop-medicatieafspraken (staken) || Het systeem levert correcte stop-medicatieafspraak (staken) op
|-style="vertical-align:top; style="background-color: white;"
|Aantonen dat het systeem correct omgaat met het beschikbaarstellen van technische stop-medicatieafspraken als onderdeel van een wijziging
||Het systeem levert een inhoudelijk correcte technische stop-medicatieafspraak op in het geval van een wijziging. De technische stop-medicatieafspraak wordt niet als zodanig getoond aan de eindgebruiker.
|-style="vertical-align:top; style="background-color: white;"
|Aantonen dat het systeem correct omgaat met de reden wijzigen of staken ||Het systeem gaat correct om met de reden wijzigen of staken. De reden van wijzigen wordt opgeleverd in de nieuwe medicatieafspraak.
|-style="vertical-align:top; style="background-color: white;"
|Aantonen dat het systeem correct omgaat met het beschikbaarstellen van tijdelijk onderbroken medicatieafspraken||Het systeem levert een stop-medicatieafspraak (onderbreken) op
|}

=== Scenario’s ===

<font color=#FF0000>LET OP: onderstaande scenario's bevatten medicatieafspraken welke gestopt (tijdelijk/definitief) of gewijzigd zijn.</font>
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-3 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-4 }}
<br>
<br>
<br>

== Scenarioset 4 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 5 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 6: medicatieafspraken met diverse doseerschema's ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-6 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-3 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-4 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-5 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-6 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7a }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7b }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-8 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-9 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-10 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-11 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-12 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-13 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-14 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-15 }}
<br>
<br>
<br>

== Scenarioset 7: medicatieafspraken met magistraal/eigen artikel ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-7 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset7-v20-7-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-2 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-3 }}
<br>
<br>
<br>

== Scenarioset 8: andermans medicatieafspraak ==
{{NoteBox|Scenarioset 8 is van toepassing voor ''Medicatiegegevens beschikbaarstellend systeem (MP-MGB) - MA'' indien leverancier al gekwalificeerd is voor ''Medicatiegegevens raadplegend systeem (MP-MGR) - MA''}}
=== Doel en verwacht resultaat ===

{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Doel|| Verwacht resultaat
|-style="vertical-align:top;|style="background-color: white;"
|Aantonen dat er geen medicatieafspraken van een ander opgeleverd worden ||Het systeem levert geen medicatieafspraken op met kopie indicator.
|}

=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-8 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset8-v20-8-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset8-v20-8-1 }}
<br>
<br>
<br>

== Scenarioset 9 ==
Niet van toepassing.
<br>
<br>

== Scenarioset 10: medicatieafspraak o.b.v. HPK of ZI-nr ==
=== Scenario’s ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|overview-MGR-10 }}

=== Inhoudelijke gegevens ===
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|patient-mg-mp-mg-tst-MA-Scenarioset10-v20-10-1 }}

{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset10-v20-10-1 }}
{{#lst:mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|mbhs-mg-mp-mg-tst-MA-Scenarioset10-v20-10-2 }}
<br>
<br>
<br>

== Documenthistorie ==
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Datum||Omschrijving
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-04-05
|style="background-color: white;"| publicatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-05-23
|style="background-color: white;"| Code bij "Reden van voorschrijven" scenario 2.3 correctie [https://bits.nictiz.nl/browse/MP-593 BITS MP-593]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|style="background-color: white;"| 2022-11-17
|style="background-color: white;"| Patiënt gegevens aangepast [https://bits.nictiz.nl/browse/MP-648 BITS MP-648]
|}

<font style="color: #B5B5B5;">
Deze pagina maakt gebruik van diverse sections uit addendum 'database': [[mp:V2.0.0_testgegevens_medicatiegegevens_MA_addendum|<font style="color: #B5B5B5;">''testgegevens medicatiegegevens medicatieafspraak addendum''</font>]]. </font>

mp:V2.0.0 testgegevens medicatiegegevens MA addendum

2022-11-17T09:52:00Z

Tim Schuller:

__NUMBEREDHEADINGS__
{{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens 9 2.0 - MA: addendum inhoudelijke gegevens kwalificatie}}

=Addenda voor inhoudelijke gegevens=
== Overzicht van scenario's voor sturend/beschikbaarstellend systeem ==

=== Scenarioset 0===
<section begin=overview-MGB-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| || Alle medicatieafspraken van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 6 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| || Specifieke medicatieafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_200_QA1_MA" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
|-style="vertical-align:top;|style="background-color: white;"
|0.3 optioneel|| || Medicatieafspraken met een filter op productcode (PRK 3956)<br/>(Antwoord: bericht met 1 medicatieafspraak)
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| || Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21)<br/>(Antwoord: bericht met 4 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| || Medicatieafspraken met een filter op gebruiksperiode – einddatum (alles voor T-22)<br/>(Antwoord: bericht met 3 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.6|| || Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7)<br/>(Antwoord: bericht met 3 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.7|| || Medicatieafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_200_QA1" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
|-style="vertical-align:top;|style="background-color: white;"
|0.8|| || Een antwoord zonder medicatieafspraken (filter op gebruiksperiode – einddatum (alles voor T-110))<br/>(Antwoord: bericht zonder medicatieafspraken)
|}
<section end=overview-MGB-0 />
=== Scenarioset 1===
<section begin=overview-MGB-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|1.1*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| Medicatieafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_200_start_eind|| MBH_200_start_eind_MA
|-style="vertical-align:top;|style="background-color: white;"
|1.2a*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_200_start_duur|| MBH_200_start_duur_MA
|-style="vertical-align:top;|style="background-color: white;"
|1.2b*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_200_start_duur2|| MBH_200_start_duur2_MA
|-style="vertical-align:top;|style="background-color: white;"
|1.3|| || Medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_200_chronisch|| MBH_200_chronisch_MA
|-style="vertical-align:top;|style="background-color: white;"
|1.4|| || Medicatieafspraak met eenheid 'dosis/stuks'|| MBH_200_dosis_stuks|| MBH_200_dosis_stuks_MA
|}
<section end=overview-MGB-1 />
=== Scenarioset 2===
<section begin=overview-MGB-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje)|| Aanvullende instructie|| MBH_200_aanvullendeinstructie|| MBH_200_aanvullendeinstructie_MA
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_200_toelichting|| MBH_200_toelichting_MA
|-style="vertical-align:top;|style="background-color: white;"
|2.3|| Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld.|| Reden van voorschrijven|| MBH_200_redenvanvoorschrijven|| MBH_200_redenvanvoorschrijven_MA
|-style="vertical-align:top;|style="background-color: white;"
|2.4|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' zichtbaar is|| Aanvullende informatie|| MBH_200_aanvullendeinformatiewensen|| MBH_200_aanvullendeinformatiewensen_MA
|-style="vertical-align:top;|style="background-color: white;"
|2.5|| Maak screenshot(s) waarop de toelichting zichtbaar is|| Toedieningsweg|| MBH_200_Toedieningsweg|| MBH_200_Toedieningsweg_MA
|}
<section end=overview-MGB-2 />
=== Scenarioset 3===
<section begin=overview-MGB-3 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|3.1|| || Stop-medicatieafspraak, met reden staken|| MBH_200_stoppen|| MBH_200_stoppen_MA_start<br/>MBH_200_stoppen_MA_staken
|-style="vertical-align:top;|style="background-color: white;"
|3.2|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Wijziging medicatieafspraak, met reden wijziging|| MBH_200_wijzigen_verhoging|| MBH_200_wijzigen_verhoging_MA_start<br/>MBH_200_wijzigen_verhoging_MA_wijzigingmetVV<br/>MBH_200_wijzigen_verhoging_MA_techstaken
|-style="vertical-align:top;|style="background-color: white;"
|3.3|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Wijziging medicatieafspraak, met reden wijziging || MBH_200_wijzigen_verlaging|| MBH_200_wijzigen_verlaging_MA_start<br/>MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV<br/>MBH_200_wijzigen_verlaging_MA_techstaken
|-style="vertical-align:top;|style="background-color: white;"
|3.4 || Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Onderbreken medicatieafspraak|| MBH_200_onderbreken|| MBH_200_onderbreken_MA_start<br/>MBH_200_onderbreken_MA_onderbreken
|-style="vertical-align:top;|style="background-color: white;"
|3.5|| || || MBH_200_TAwijzigen|| MBH_200_TAwijzigen_MA
|}
<section end=overview-MGB-3 />
=== Scenarioset 6===
<section begin=overview-MGB-6 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|6.1|| || Variabele frequentie|| MBH_200_variabelefrequentie|| MBH_200_variabelefrequentie_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.2|| || Interval|| MBH_200_interval|| MBH_200_interval_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.3|| || Variabele hoeveelheid (1)|| MBH_200_variabelehoeveelheid|| MBH_200_variabelehoeveelheid_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.4|| || Zonder keerdosis|| MBH_200_zonderkeerdosis|| MBH_200_zonderkeerdosis_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.5|| || Bijzondere keerdosis|| MBH_200_bijzonderekeerdosis|| MBH_200_bijzonderekeerdosis_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.6|| || Variabele hoeveelheid (2)|| MBH_200_variabelehoeveelheid2|| MBH_200_variabelehoeveelheid2_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.7a|| || Tijdstippen flexibel|| MBH_200_tijdstippen_flexibel|| MBH_200_tijdstippen_flexibel_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.7b|| Maak screenshot(s) waarop zichtbaar is dat tijdstip gekozen kan worden|| Tijdstippen niet flexibel|| MBH_200_tijdstippen_niet_flexibel|| MBH_200_tijdstippen_niet_flexibel_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.8|| Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden|| Weekdagen|| MBH_200_weekdagen|| MBH_200_weekdagen_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.9|| Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden|| Dagdeel|| MBH_200_dagdeel|| MBH_200_dagdeel_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.10|| Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden|| Cyclisch schema|| MBH_200_cyclischschema|| MBH_200_cyclischschema_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.11|| Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden|| Afbouw schema en doseerduur|| MBH_200_afbouwschema|| MBH_200_afbouwschema_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.12|| || Variabele hoeveelheid en maximum|| MBH_200_variabelehoeveelheidenmaximum|| MBH_200_variabelehoeveelheidenmaximum_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.13|| || Toedieningssnelheid|| MBH_200_toedieningssnelheid|| MBH_200_toedieningssnelheid_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.14|| || Toedieningsduur|| MBH_200_toedieningsduur|| MBH_200_toedieningsduur_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.15|| Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid)|| Zo nodig|| MBH_200_zonodig|| MBH_200_zonodig_MA
|}
<section end=overview-MGB-6 />
=== Scenarioset 7===
<section begin=overview-MGB-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_200_magistraalalleingredienten|| MBH_200_magistraalalleingredienten_MA
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_200_magistraalactieveingredient|| MBH_200_magistraalactieveingredient_MA
|-style="vertical-align:top;|style="background-color: white;"
|7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_200_magistraal90miljoennr|| MBH_200_magistraal90miljoennr_MA
|}
<section end=overview-MGB-7 />
=== Scenarioset 10===
<section begin=overview-MGB-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| || HPK geneesmiddel|| MBH_200_HPKvoorschrijven|| MBH_200_HPKvoorschrijven_MA
|-style="vertical-align:top;|style="background-color: white;"
|10.2|| || ZI-nr geneesmiddel|| MBH_200_ZINRvoorschrijven|| MBH_200_ZINRvoorschrijven_MA
|}
<section end=overview-MGB-10 />
== Overzicht van scenario's voor ontvangend/raadplegend systeem ==

=== Scenarioset 0===
<section begin=overview-MGR-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| Alle medicatieafspraken van de patiënt, zonder aanvullend filtercriterium<br/>(Antwoord: bericht met 6 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| Specifieke medicatieafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_200_QA1_MA" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
|-style="vertical-align:top;|style="background-color: white;"
|0.3|| Medicatieafspraken met een filter op productcode (PRK 3956)<br/>(Antwoord: bericht met 1 medicatieafspraak)
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21)<br/>(Antwoord: bericht met 4 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| Medicatieafspraken met een filter op gebruiksperiode – einddatum (alles voor T-22)<br/>(Antwoord: bericht met 3 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.6|| Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7)<br/>(Antwoord: bericht met 3 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.7|| Medicatieafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_200_QA1" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
|-style="vertical-align:top;|style="background-color: white;"
|0.8|| Een antwoord zonder medicatieafspraken (filter op gebruiksperiode – einddatum (alles voor T-110))<br/>(Antwoord: bericht zonder medicatieafspraken)
|}
<section end=overview-MGR-0 />
=== Scenarioset 1===
<section begin=overview-MGR-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|1.1|| Medicatieafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_200_start_eind|| MBH_200_start_eind_MA
|-style="vertical-align:top;|style="background-color: white;"
|1.2a|| Medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_200_start_duur|| MBH_200_start_duur_MA
|-style="vertical-align:top;|style="background-color: white;"
|1.2b|| Medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_200_start_duur2|| MBH_200_start_duur2_MA
|-style="vertical-align:top;|style="background-color: white;"
|1.3|| Medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_200_chronisch|| MBH_200_chronisch_MA
|-style="vertical-align:top;|style="background-color: white;"
|1.4|| Medicatieafspraak met eenheid 'dosis/stuks'|| MBH_200_dosis_stuks|| MBH_200_dosis_stuks_MA
|}
<section end=overview-MGR-1 />
=== Scenarioset 2===
<section begin=overview-MGR-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| Aanvullende instructie|| MBH_200_aanvullendeinstructie|| MBH_200_aanvullendeinstructie_MA
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Toelichting|| MBH_200_toelichting|| MBH_200_toelichting_MA
|-style="vertical-align:top;|style="background-color: white;"
|2.3|| Reden van voorschrijven|| MBH_200_redenvanvoorschrijven|| MBH_200_redenvanvoorschrijven_MA
|-style="vertical-align:top;|style="background-color: white;"
|2.4|| Aanvullende informatie|| MBH_200_aanvullendeinformatiewensen|| MBH_200_aanvullendeinformatiewensen_MA
|-style="vertical-align:top;|style="background-color: white;"
|2.5|| Toedieningsweg|| MBH_200_Toedieningsweg|| MBH_200_Toedieningsweg_MA
|}
<section end=overview-MGR-2 />
=== Scenarioset 3===
<section begin=overview-MGR-3 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|3.1|| Stop-medicatieafspraak, met reden staken|| MBH_200_stoppen|| MBH_200_stoppen_MA_start<br/>MBH_200_stoppen_MA_staken
|-style="vertical-align:top;|style="background-color: white;"
|3.2|| Wijziging medicatieafspraak, met reden wijziging|| MBH_200_wijzigen_verhoging|| MBH_200_wijzigen_verhoging_MA_start<br/>MBH_200_wijzigen_verhoging_MA_wijzigingmetVV<br/>MBH_200_wijzigen_verhoging_MA_techstaken
|-style="vertical-align:top;|style="background-color: white;"
|3.3|| Wijziging medicatieafspraak, met reden wijziging || MBH_200_wijzigen_verlaging|| MBH_200_wijzigen_verlaging_MA_start<br/>MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV<br/>MBH_200_wijzigen_verlaging_MA_techstaken
|-style="vertical-align:top;|style="background-color: white;"
|3.4|| Onderbreken medicatieafspraak|| MBH_200_onderbreken|| MBH_200_onderbreken_MA_start<br/>MBH_200_onderbreken_MA_onderbreken
|-style="vertical-align:top;|style="background-color: white;"
|3.5|| || MBH_200_TAwijzigen|| MBH_200_TAwijzigen_MA
|}
<section end=overview-MGR-3 />
=== Scenarioset 6===
<section begin=overview-MGR-6 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|6.1|| Variabele frequentie|| MBH_200_variabelefrequentie|| MBH_200_variabelefrequentie_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.2|| Interval|| MBH_200_interval|| MBH_200_interval_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.3|| Variabele hoeveelheid (1)|| MBH_200_variabelehoeveelheid|| MBH_200_variabelehoeveelheid_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.4|| Zonder keerdosis|| MBH_200_zonderkeerdosis|| MBH_200_zonderkeerdosis_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.5|| Bijzondere keerdosis|| MBH_200_bijzonderekeerdosis|| MBH_200_bijzonderekeerdosis_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.6|| Variabele hoeveelheid (2)|| MBH_200_variabelehoeveelheid2|| MBH_200_variabelehoeveelheid2_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.7a|| Tijdstippen flexibel|| MBH_200_tijdstippen_flexibel|| MBH_200_tijdstippen_flexibel_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.7b|| Tijdstippen niet flexibel|| MBH_200_tijdstippen_niet_flexibel|| MBH_200_tijdstippen_niet_flexibel_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.8|| Weekdagen|| MBH_200_weekdagen|| MBH_200_weekdagen_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.9|| Dagdeel|| MBH_200_dagdeel|| MBH_200_dagdeel_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.10|| Cyclisch schema|| MBH_200_cyclischschema|| MBH_200_cyclischschema_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.11|| Afbouw schema en doseerduur|| MBH_200_afbouwschema|| MBH_200_afbouwschema_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.12|| Variabele hoeveelheid en maximum|| MBH_200_variabelehoeveelheidenmaximum|| MBH_200_variabelehoeveelheidenmaximum_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.13|| Toedieningssnelheid|| MBH_200_toedieningssnelheid|| MBH_200_toedieningssnelheid_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.14|| Toedieningsduur|| MBH_200_toedieningsduur|| MBH_200_toedieningsduur_MA
|-style="vertical-align:top;|style="background-color: white;"
|6.15|| Zo nodig|| MBH_200_zonodig|| MBH_200_zonodig_MA
|}
<section end=overview-MGR-6 />
=== Scenarioset 7===
<section begin=overview-MGR-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|7.1|| Alle ingrediënten|| MBH_200_magistraalalleingredienten|| MBH_200_magistraalalleingredienten_MA
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| Actief ingrediënt|| MBH_200_magistraalactieveingredient|| MBH_200_magistraalactieveingredient_MA
|-style="vertical-align:top;|style="background-color: white;"
|7.3|| 90 miljoen nummer|| MBH_200_magistraal90miljoennr|| MBH_200_magistraal90miljoennr_MA
|}
<section end=overview-MGR-7 />
=== Scenarioset 10===
<section begin=overview-MGR-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| HPK geneesmiddel|| MBH_200_HPKvoorschrijven|| MBH_200_HPKvoorschrijven_MA
|-style="vertical-align:top;|style="background-color: white;"
|10.2|| ZI-nr geneesmiddel|| MBH_200_ZINRvoorschrijven|| MBH_200_ZINRvoorschrijven_MA
|}
<section end=overview-MGR-10 />
== TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MA-Scenarioset0-v20-0-1 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-1 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-1 />
==== Scenario 0.1 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA1_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA2_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 100 dagen om 08:04 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 72 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 10 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA3_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA4_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA5====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA5_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 08:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|4 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.1 - MBH_200_QA6====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA6_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 08:18 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-1 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v20-0-1 />
== TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MA-Scenarioset0-v20-0-2 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-2 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-2 />
==== Scenario 0.2 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA1_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-2 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v20-0-2 />
== TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MA-Scenarioset0-v20-0-3optioneel /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-3optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-3optioneel /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-3optioneel />
==== Scenario 0.3 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA4_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-3optioneel /><section end=mg-mp-mg-tst-MA-Scenarioset0-v20-0-3optioneel />
== TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MA-Scenarioset0-v20-0-4 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-4 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-4 />
==== Scenario 0.4 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA1_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA3_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA4_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.4 - MBH_200_QA6====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA6_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 08:18 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-4 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v20-0-4 />
== TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MA-Scenarioset0-v20-0-5 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-5 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-5 />
==== Scenario 0.5 - MBH_200_QA2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA2_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 100 dagen om 08:04 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 100 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 72 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 10 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.5 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA3_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.5 - MBH_200_QA5====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA5_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 08:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|4 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-5 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v20-0-5 />
== TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MA-Scenarioset0-v20-0-6 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-6 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-6 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-6 />
==== Scenario 0.6 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA1_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.6 - MBH_200_QA3====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA3_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 50 dagen om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 50 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 11 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 50 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Scenario 0.6 - MBH_200_QA4====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA4_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 19 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-6 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v20-0-6 />
== TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MA-Scenarioset0-v20-0-7 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-7 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-7 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-7 />
==== Scenario 0.7 - MBH_200_QA1====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA1_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 9 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-7 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v20-0-7 />
== TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mp-mg-tst-MA-Scenarioset0-v20-0-8 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-8 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Sonnenberg
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901084 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|20 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v20-0-8 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-8 /><section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20-0-8 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v20-0-8 />
== TEST Medicatiegegevens MA Scenarioset 1==
<section begin=mg-mp-mg-tst-MA-Scenarioset1-v20-1-1 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-1 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-1 />
==== Scenario 1.1 - MBH_200_start_eind====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_start_eind_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 11:20 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 10 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-1 /><section end=mg-mp-mg-tst-MA-Scenarioset1-v20-1-1 />
== TEST Medicatiegegevens MA Scenarioset 1==
<section begin=mg-mp-mg-tst-MA-Scenarioset1-v20-1-2a /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2a />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2a /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2a />
==== Scenario 1.2a - MBH_200_start_duur====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_start_duur_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 20 dagen om 11:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 20 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|3 weken
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2a /><section end=mg-mp-mg-tst-MA-Scenarioset1-v20-1-2a />
== TEST Medicatiegegevens MA Scenarioset 1==
<section begin=mg-mp-mg-tst-MA-Scenarioset1-v20-1-2b /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2b />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2b /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2b />
==== Scenario 1.2b - MBH_200_start_duur2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_start_duur2_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 60 dagen om 11:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-2b /><section end=mg-mp-mg-tst-MA-Scenarioset1-v20-1-2b />
== TEST Medicatiegegevens MA Scenarioset 1==
<section begin=mg-mp-mg-tst-MA-Scenarioset1-v20-1-3 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-3 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-3 />
==== Scenario 1.3 - MBH_200_chronisch====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_chronisch_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 30 dagen om 11:32 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-3 /><section end=mg-mp-mg-tst-MA-Scenarioset1-v20-1-3 />
== TEST Medicatiegegevens MA Scenarioset 1==
<section begin=mg-mp-mg-tst-MA-Scenarioset1-v20-1-4 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dijks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900468 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|21 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset1-v20-1-4 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-4 />
==== Scenario 1.4 - MBH_200_dosis_stuks====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_dosis_stuks_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 130 dagen om 11:35 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 130 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 101 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 dosis
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20-1-4 /><section end=mg-mp-mg-tst-MA-Scenarioset1-v20-1-4 />
== TEST Medicatiegegevens MA Scenarioset 2==
<section begin=mg-mp-mg-tst-MA-Scenarioset2-v20-2-1 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-1 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-1 />
==== Scenario 2.1 - MBH_200_aanvullendeinstructie====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_aanvullendeinstructie_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 4 maanden om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 8 maanden''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 4 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 8 maanden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 8 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-1 /><section end=mg-mp-mg-tst-MA-Scenarioset2-v20-2-1 />
== TEST Medicatiegegevens MA Scenarioset 2==
<section begin=mg-mp-mg-tst-MA-Scenarioset2-v20-2-2 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-2 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-2 />
==== Scenario 2.2 - MBH_200_toelichting====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_toelichting_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 21 dagen om 08:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toelichting
|style="background-color: white;"|In overleg met specialist
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-2 /><section end=mg-mp-mg-tst-MA-Scenarioset2-v20-2-2 />
== TEST Medicatiegegevens MA Scenarioset 2==
<section begin=mg-mp-mg-tst-MA-Scenarioset2-v20-2-3 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-3 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-3 />
==== Scenario 2.3 - MBH_200_redenvanvoorschrijven====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_redenvanvoorschrijven_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 13 dagen om 08:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 13 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden van voorschrijven
|style="background-color: white;"|Reumatoide artritis (code = 'L88.01' in codeSystem 'ICPC-1'): Reumatoide artritis
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 5 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per week 5 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-3 /><section end=mg-mp-mg-tst-MA-Scenarioset2-v20-2-3 />
== TEST Medicatiegegevens MA Scenarioset 2==
<section begin=mg-mp-mg-tst-MA-Scenarioset2-v20-2-4 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-4 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-4 />
==== Scenario 2.4 - MBH_200_aanvullendeinformatiewensen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_aanvullendeinformatiewensen_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 08:06 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aanvullende informatie
|style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-4 /><section end=mg-mp-mg-tst-MA-Scenarioset2-v20-2-4 />
== TEST Medicatiegegevens MA Scenarioset 2==
<section begin=mg-mp-mg-tst-MA-Scenarioset2-v20-2-5 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|D.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dixhoorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900481 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|22 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset2-v20-2-5 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-5 />
==== Scenario 2.5 - MBH_200_Toedieningsweg====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_Toedieningsweg_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 08:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 1 druppel
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aanvullende informatie
|style="background-color: white;"|Bewust afwijkende toedieningsweg (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20-2-5 /><section end=mg-mp-mg-tst-MA-Scenarioset2-v20-2-5 />
== TEST Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mp-mg-tst-MA-Scenarioset3-v20-3-1 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dongen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900493 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|23 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-1 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-1 />
==== Scenario 3.1 - MBH_200_stoppen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_stoppen_MA_start
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 60 dagen om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 220 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 220 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 220 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_stoppen_MA_staken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_stoppen_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 10 dagen om 18:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak stop type
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden wijzigen of staken
|style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, tot en met T, 1 maal per dag 1 stuk, Oraal, definitief gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-1 /><section end=mg-mp-mg-tst-MA-Scenarioset3-v20-3-1 />
== TEST Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mp-mg-tst-MA-Scenarioset3-v20-3-2 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dongen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900493 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|23 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-2 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-2 />
==== Scenario 3.2 - MBH_200_wijzigen_verhoging====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_wijzigen_verhoging_MA_start
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 21 dagen om 08:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_wijzigen_verhoging_MA_wijzigingmetVV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 2 dagen om 08:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden wijzigen of staken
|style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 2 dagen, 1 maal per dag 2 stuks, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_wijzigen_verhoging_MA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 2 dagen om 08:02 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 3 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak stop type
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-2 /><section end=mg-mp-mg-tst-MA-Scenarioset3-v20-3-2 />
== TEST Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mp-mg-tst-MA-Scenarioset3-v20-3-3 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dongen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900493 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|23 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-3 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-3 />
==== Scenario 3.3 - MBH_200_wijzigen_verlaging====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_wijzigen_verlaging_MA_start
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 13 dagen om 08:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 13 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 13 dagen, tot en met T + 14 dagen, 2 maal per week 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden wijzigen of staken
|style="background-color: white;"|te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 1 dag, tot en met T + 14 dagen, 1 maal per week 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_wijzigen_verlaging_MA_techstaken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T - 2 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 13 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 2 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak stop type
|style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 13 dagen, tot en met T - 2 dagen, 2 maal per week 1 stuk, Oraal, definitief gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per week 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-3 /><section end=mg-mp-mg-tst-MA-Scenarioset3-v20-3-3 />
== TEST Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mp-mg-tst-MA-Scenarioset3-v20-3-4 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dongen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900493 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|23 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-4 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-4 />
==== Scenario 3.4 - MBH_200_onderbreken====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_onderbreken_MA_start
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 5 dagen om 08:06 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 5 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_onderbreken_MA_onderbreken
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_onderbreken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 1 dag om 18:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T - 1 dag''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 4 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak stop type
|style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden wijzigen of staken
|style="background-color: white;"|verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 4 dagen, tot en met T - 1 dag, 3 maal per dag 1 stuk, Oraal, tijdelijk gestopt
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Relatie medicatieafspraak
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Identificatie
|style="background-color: white;"|MBH_200_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-4 /><section end=mg-mp-mg-tst-MA-Scenarioset3-v20-3-4 />
== TEST Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mp-mg-tst-MA-Scenarioset3-v20-3-5 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Dongen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900493 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|23 okt 1963
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset3-v20-3-5 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-5 />
==== Scenario 3.5 - MBH_200_TAwijzigen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_TAwijzigen_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 60 dagen om 11:30 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 60 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Gebruiksduur
|style="background-color: white;"|28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Bertine van Doorn
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20-3-5 /><section end=mg-mp-mg-tst-MA-Scenarioset3-v20-3-5 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-1 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-1 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-1 />
==== Scenario 6.1 - MBH_200_variabelefrequentie====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_variabelefrequentie_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 16 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 à 2 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-1 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-1 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-2 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-2 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-2 />
==== Scenario 6.2 - MBH_200_interval====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_interval_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:04 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, iedere 8 uur 1 stuk - let op, tijden exact aanhouden, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|iedere 8 uur 1 stuk - let op, tijden exact aanhouden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-2 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-2 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-3 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-3 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-3 />
==== Scenario 6.3 - MBH_200_variabelehoeveelheid====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_variabelehoeveelheid_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:10 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag 1 à 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag 1 à 2 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-3 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-3 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-4 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-4 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-4 />
==== Scenario 6.4 - MBH_200_zonderkeerdosis====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_zonderkeerdosis_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:12 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|3 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-4 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-4 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-5 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-5 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-5 />
==== Scenario 6.5 - MBH_200_bijzonderekeerdosis====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_bijzonderekeerdosis_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 0.5 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-5 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-5 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-6 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-6 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-6 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-6 />
==== Scenario 6.6 - MBH_200_variabelehoeveelheid2====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_variabelehoeveelheid2_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:18 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|2 maal per dag 10 à 15 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-6 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-6 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-7a /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7a />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7a /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7a />
==== Scenario 6.7a - MBH_200_tijdstippen_flexibel====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_tijdstippen_flexibel_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:24 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 14 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7a /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-7a />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-7b /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7b />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7b /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7b />
==== Scenario 6.7b - MBH_200_tijdstippen_niet_flexibel====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_tijdstippen_niet_flexibel_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 09:15 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 7 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 7 dagen, elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, tijden exact aanhouden, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, tijden exact aanhouden
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-7b /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-7b />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-8 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-8 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-8 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-8 />
==== Scenario 6.8 - MBH_200_weekdagen====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_weekdagen_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:25 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 70 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 70 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|op maandag, woensdag en vrijdag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-8 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-8 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-9 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-9 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-9 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-9 />
==== Scenario 6.9 - MBH_200_dagdeel====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_dagdeel_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:27 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, 1 stuk 's avonds, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 stuk 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-9 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-9 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-10 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-10 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-10 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-10 />
==== Scenario 6.10 - MBH_200_cyclischschema====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_cyclischschema_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:33 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Herhaalperiode cyclisch schema
|style="background-color: white;"|28 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-10 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-10 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-11 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-11 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-11 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-11 />
==== Scenario 6.11 - MBH_200_afbouwschema====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_afbouwschema_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:40 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 41 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 41 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 1
|style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 3
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-11 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-11 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-12 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-12 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-12 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-12 />
==== Scenario 6.12 - MBH_200_variabelehoeveelheidenmaximum====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_variabelehoeveelheidenmaximum_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:45 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-12 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-12 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-13 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-13 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-13 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-13 />
==== Scenario 6.13 - MBH_200_toedieningssnelheid====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_toedieningssnelheid_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:47 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 8 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur, parenteraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-13 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-13 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-14 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-14 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-14 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-14 />
==== Scenario 6.14 - MBH_200_toedieningsduur====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_toedieningsduur_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:49 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk gedurende 16 uur, transdermaal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-14 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-14 />
== TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mp-mg-tst-MA-Scenarioset6-v20-6-15 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-15 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaldo
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900936 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|7 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20-6-15 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-15 />
==== Scenario 6.15 - MBH_200_zonodig====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_zonodig_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 08:57 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 27 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 27 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20-6-15 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20-6-15 />
== TEST Medicatiegegevens MA Scenarioset 7 (Magistraal)==
<section begin=mg-mp-mg-tst-MA-Scenarioset7-v20-7-1 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset7-v20-7-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset7-v20-7-1 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-1 />
==== Scenario 7.1 - MBH_200_magistraalalleingredienten====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_200_magistraalalleingredienten_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 12:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 31 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 31 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="11"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 31 dagen, Zo nodig, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|Zo nodig
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-1 /><section end=mg-mp-mg-tst-MA-Scenarioset7-v20-7-1 />
== TEST Medicatiegegevens MA Scenarioset 7 (Magistraal)==
<section begin=mg-mp-mg-tst-MA-Scenarioset7-v20-7-2 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset7-v20-7-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset7-v20-7-2 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-2 />
==== Scenario 7.2 - MBH_200_magistraalactieveingredient====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_200_magistraalactieveingredient_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 12:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 70 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T + 1 dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 70 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-2 /><section end=mg-mp-mg-tst-MA-Scenarioset7-v20-7-2 />
== TEST Medicatiegegevens MA Scenarioset 7 (Magistraal)==
<section begin=mg-mp-mg-tst-MA-Scenarioset7-v20-7-3 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset7-v20-7-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|M.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Rambaran Mishre
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999900948 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|8 nov 1985
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset7-v20-7-3 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-3 />
==== Scenario 7.3 - MBH_200_magistraal90miljoennr====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_200_magistraal90miljoennr_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatie
|style="background-color: white;"|MBH_200_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 12:08 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 30 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Einddatum
|style="background-color: white;"|T + 30 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Geneesmiddel - Product specificatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="8"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product code
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Product naam
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Ingredient
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingredient code
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Sterkte
|style="background-color: white;"| per
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toedieningsweg
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Doseerinstructie
|style="background-color: white;"|1 maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|MBH identificatie
|style="background-color: white;"|MBH_200_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20-7-3 /><section end=mg-mp-mg-tst-MA-Scenarioset7-v20-7-3 />
== TEST Medicatiegegevens MA Scenarioset 10 (HPKZI)==
<section begin=mg-mp-mg-tst-MA-Scenarioset10-v20-10-1 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset10-v20-10-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|J.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Bree
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901588 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jul 2010
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset10-v20-10-1 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset10-v20-10-1 />
==== Scenario 10.1 - MBH_200_HPKvoorschrijven====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_HPKvoorschrijven_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T - 170 dagen om 13:00 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T - 170 dagen, tot en met T - 21 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T - 170 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T - 21 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset10-v20-10-1 /><section end=mg-mp-mg-tst-MA-Scenarioset10-v20-10-1 />
== TEST Medicatiegegevens MA Scenarioset 10 (HPKZI)==
<section begin=mg-mp-mg-tst-MA-Scenarioset10-v20-10-2 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset10-v20-10-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|J.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Bree
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999901588 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1 jul 2010
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender')
|}<section end=patient-mg-mp-mg-tst-MA-Scenarioset10-v20-10-2 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset10-v20-10-2 />
==== Scenario 10.2 - MBH_200_ZINRvoorschrijven====

{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_ZINRvoorschrijven_MA
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_200_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Medicatieafspraak datum tijd
|style="background-color: white;"|T om 13:05 uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Gebruiksperiode
|style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen''
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Ingangsdatum
|style="background-color: white;"|T
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Einddatum
|style="background-color: white;"|T + 150 dagen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - primaire code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Geneesmiddel - generiekere code
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_200_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
|}
==== Bouwstenen ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde

|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgverlener identificatienummer
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgegevens
|style="background-color: white;"|Peter van Pulver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Specialisme
|style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Zorgaanbieder
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgaanbieder
|style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span>
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Zorgaanbieder identificatienummer
|style="background-color: white;"|00001111 (in identificerend systeem: URA)
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Organisatie naam
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Adresgegevens
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
|}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset10-v20-10-2 /><section end=mg-mp-mg-tst-MA-Scenarioset10-v20-10-2 />

[[Categorie:Kwalificatie]]